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 Abstract 
Conventional cancer therapy, such as γ-irradiation and cytotoxic drugs, acts via DNA 
damage-induced apoptosis and inhibition of proliferation. Major problems with 
conventional cancer therapy are that only subgroups of patients respond favourably to 
a given treatment, and that side effects often limit the dose efficiency of the 
treatment. The immune cells of the patient may for instance commit to apoptosis as a 
result of the therapy. It is therefore a constant search for modulators of DNA damage 
responses to improve such cancer therapies. To identify potential modulators it is 
important to have good read out systems. One of the key proteins down stream of the 
DNA damage checkpoint is the tumour suppressor p53. Upon DNA damage, the 
transcription factor p53 is stabilized and activated to affect target genes involved in 
growth arrest, DNA repair and apoptosis. Testing the efficacy of a given modulator of 
DNA damage responses may therefore include analysis of p53 expression and 
activity. 
Vitamin A plays an important role in the immune system to protect against infection, 
and deficiency of this vitamin affects more than 100 million children throughout the 
world.  One of the important metabolites of vitamin A is retinoic acid (RA), and RA 
is a well known regulator of cell proliferation and differentiation of numerous cell 
types, including lymphoid cells. The purpose of the present study was to explore a 
possible role of RA as a modulator of DNA damage responses in lymphocytes, and in 
particular we wished to elucidate the effects of RA on regulation of p53 expression in 
this process. Freshly isolated lymphocytes from healthy blood donors were stimulated 
with mitogens and treated with RA prior to induction of DNA damage by γ-
irradiation. The amount of apoptotic cells was measured by flow cytometry, and 
Western blot analysis was performed to identify p53 expression. We were able to 
show that although RA stimulates and inhibits the proliferation of normal T - and B 
cells, respectively, DNA damage-induced apoptosis was inhibited in both cell types. 
The effect of RA was particularly strong in TPA-stimulated T cells, and we could 
show that apoptosis induced by both γ-irradiation and the cytotoxic drug doxorubicin 
  - 14 -
 was inhibited. Importantly, we also showed that the RA-mediated inhibition of DNA 
damage-induced apoptosis was associated with reduced expression of p53, indicating 
that RA affects the DNA damage checkpoint. The physiological implications of the 
present results in that the vitamin A status of a cancer patient receiving chemotherapy 
or irradiation might influence the effect of the treatment, both by affecting the killing 
of malignant lymphocytes, as well as to protect the immune system from unwanted 
damage during irradiation or chemotherapy. 
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ATM 
ATR 
at-RA 
Bcl-2 
BID 
Bis 
BRAC-1 
C 
cAMP 
Cdk 
CHK 
CI 
CIP 
CKI 
Con A 
COP-1 
CRBP 
CREBP 
dH2O 
DNA 
DR 
Amino acid 
Activated T cell autonomous death  
Activation-induced cell death  
Acute myeloid leukemia  
Apoptotic protease activating factor 1  
Acute promyelocytic leukemia  
Ammonium persulphate 
Acyl CoA:retinol acyltransferase 
Ataxia-telangiectasia 
Ataxia-telangiectasia mutated 
Ataxia-telangiectasia mutated and RDS related 
All-trans retinoic acid 
B cell lymphoma 
BH3-interacting domain death agonist 
N,N- methylene bisacrylamide 
Breast cancer susceptibility protein 1 
Carboxy 
Cyclic adenosine monophosphate 
Cyclin dependent kinase 
Checkpoint kinase  
Confidence interval (in statistics) 
Members of CKI 
Cyclin dependent kinase inhibitor 
Concanvalin A 
Coat protein complex 1 
Cellular retinol binding protein 
cAMP response element binding protein 
Distilled water 
Deoxyribonucleic acid 
Direct repeat 
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1. Introduction 
1.1 Vitamin A 
Vitamin A plays an important role in vision, bone growth, reproduction, cell division 
and -differentiation, as well as in the immune system (1;2). The major form of 
vitamin A is retinol (ROH), but vitamin A is defined as ROH and other retinoids with 
the same biological activity as ROH. 
1.1.1 Vitamin A metabolism 
There are two categories of vitamin A, depending on whether the food source is 
animal-derived (retinyl ester), or plant-derived (carotenoids). Retinyl esters (RE) are 
absorbed in the form of ROH after being hydrolyzed in the intestine by the pancreatic 
enzyme triglyceride lipase, and by the intestinal brush-border enzyme phospholipase 
B (3). Sources include liver, egg, fatty fish, whole milk, margarine and fish-liver oil. 
Carotenoids are found in colourful fruits and vegetables such as carrots and spinach, 
and include α- β- and λ-carotene, as well as cryptoxanthin. β-carotene is efficiently 
metabolized into ROH, providing two molecules of ROH from one molecule of β-
carotene (4). 
After absorption into the enterocytes, carotenoids are either metabolized to retinal or 
absorbed intact into the lymph. Retinal reductase reduces retinal to ROH, and ROH is 
bound to cellular retinol-binding protein type II (CRBP II) in the enterocytes. ROH in 
complex with CRBP II is estrified to RE by the two enzymes lecitin:retinol 
acyltransferase (LRAT) and acyl-CoA:retinol acyltransferase (ARAT). RE is 
incorporated into chylomicrons together with other neutral lipid esters, and secreted 
into the lymph (3). 
1. Introduction 
 
 
Figure 1: The absorption of vitamin A. Absorbed ROH is estrified to RE, 
which is incorporated into chylomicrons together with other neutral 
lipid esters, and secreted into the lymph. 
The absorbed RE is circulated to several types of tissues, but most of the RE is 
metabolized to ROH in parenchymal liver cells. In these cells retinol binding protein 
(RBP) forms a complex with ROH, and transports ROH to nonparenchymal stellate 
cells in the liver. Here, ROH can be stored in the form of RE. Prior to mobilization 
from the liver, RE is hydrolyzed, and RBP once again binds to ROH. The ROH-RBP 
complex binds to transtyretin (TTR) in plasma, resulting in reduced glomerular 
filtration since the complex alone is too small to prevent renal filtration. The ROH-
RBP-TTR complex circulates, providing vitamin A to extrahepatic tissue when intake 
of the vitamin is low, ensuring the plasma concentration to be maintained at 
approximately 2 µM (4;5). 
1.1.2 Retinoids 
Retinoids include naturally occurring forms of vitamin A but also synthetic 
derivatives of ROH, with or without biological activity (6). 
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A number of retinoids are thought to be bound to albumin, like all-trans retinoic acid 
(atRA) and 13-cis retinoic acid, as such they are present at nanomolar concentrations 
in plasma (7). While the visual function of vitamin A depends on its metabolite 11-cis 
retinal, most of the other functions of vitamin A including immunological functions, 
depend on atRA (8). Retinal can be reversibly reduced to produce ROH or it can be 
irreversibly oxidized to produce RA (9). 
 
OH
all-trans retinol
O
H
OH
O
all-trans retinal
all-trans retinoic acid
O C (Ch2)7CH3
O
all-trans β-carotene
OHO
all-trans retinyl palmitate
9-cis retinoic acid
 
 
Figure 2: Molecular structure of some retinoids. 
Retinoic acid receptors 
Fat-soluble vitamins serve as precursors for ligands that bind to receptors in the 
nucleus. Nuclear receptors bind to specific DNA sequences known as hormone 
response elements (HREs). Each receptor recognizes unique HREs, typically direct 
repeats (DR) of the core AGGTCA half-site (10). Two important families of nuclear 
receptors include retinoic acid receptors (RARs), which bind both atRA and 9-cis 
RA, and retinoid X receptors (RXRs), which binds 9-cis RA (10;11). Each receptor 
exist in three isoforms; α, β and γ (12). Retinoic acid response element (RARE) are 
typically composed of DRs spaced by 2-5 nucleotides (DR2-DR5 respectively) and 
RXRs bind to DR1 where one nucleotide separate the repeated cores. RXR can bind 
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to DR1 both as a homodimer and as a heterodimer with RAR (10). In the absence of 
the ligand RA, RAR/RXR binding to RAREs recruits nuclear co-repressor to silence 
target gene by altering chromatin structure. Upon RA ligation, the co-repressor 
complex is released and the RAR/RXR complex associates with transcriptional co 
activators. This leads to transcription of RA-responsive genes (13;14). 
 
 
 
Figure 3: Retinoic acid receptors and its response element.  
1.2 Proliferation and cell death 
1.2.1 Regulation of the cell cycle 
The cell cycle consists of four phases: G1-phase, S-phase, G2-phase (collectively 
known as interphase) and M-phase. To produce two genetically identical daughter 
cells, the DNA must be replicated to two complete copies, and this occurs in the S-
phase (S for synthesis) of the cell cycle. M-phase is composed of two processes: 
mitosis, in which the cell's DNA is divided between the two daughter cells, and 
cytokinesis, in which the cell’s cytoplasm divides forming distinct cells. G1 and G2 
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are gap phases between the M and S phases. The two gap phases allow the cell to 
grow and double the mass of proteins and organelles, and to monitor the environment 
to ensure that conditions are suitable and preparations are complete before a new 
phase of the cell cycle starts (15). 
 
 
Figure 4: The cell cycle. The cell cycle consists of four distinct phases: G1, S 
phase, G2 (collectively known as interphase) and M phase. During interphase 
the cell grows continuously, and during M phase the cell divides. G0 is a resting 
state for quiescent cells, either temporarily or permanently. 
 
The cell cycle control system is imperative for regulating cell numbers in the tissues 
of the body. At certain points during the cycle, biochemical pathways delay or arrest 
the cell cycle progression if the internal or external conditions are not favorable. 
These points are called checkpoints. Cells that have temporarily or reversibly stopped 
dividing enter a state of quiescence called G0 phase. If everything is functioning 
normally, and any damage to the DNA has been corrected, the cell moves on through 
the cycle. If DNA damage cannot be corrected, the cell halts its progression through 
the cycle and may initiate apoptosis and close down. When the system malfunctions, 
excessive cell divisions can result in cancer (16). 
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A group of protein kinases, the cyclin dependent kinases (Cdks), are at the center of 
the cell cycle engine, phosphorylating the retinoblastoma protein (pRB). Cell 
proliferation moves forward as phosphorylated pRB dissociates with the transcription 
factor E2F, and transcription of specific S-phase genes can take place. As a monomer, 
the Cdk subunit is not active; it must associate with a cyclin subunit forming a 
heterodimeric complex. (17). There are several different Cdks and cyclins expressed 
in the different phases of the cell cycle, and specific cyclin dependent kinase 
inhibitors (CKIs) are also involved in cell cycle regulation. CKI bind to Cdk 
complexes, and inhibits the activity of the cells. Growth factors are normally required 
for a cell to pass from G1 to S-phase, and the factors stimulate the cell cycle 
machinery by activating Cdks to phosphorylate pRB (18). Upon phosphorylation, 
pRB will release the transcription factor E2F, and E2F will in turn promote 
transcription of genes required for S-phase entry, such as DNA polymerase, 
thymidine kinase, cyclin E, cyclin A etc. When pRB is phosphorylated and E2F is 
released, the cells have passed the important restriction point (R) in the G1 phase of 
the cell cycle (18). 
 
 
Figure 5: Cell cycle arrest. See text for details. 
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1.2.2 Cell death 
The process of cell death is important for both embryonic development and for 
control of cell number in tissues. Essentially, two types of cell death exist, necrosis 
and programmed cell death. The most common type of programmed cell death is 
apoptosis. In general, apoptosis confers advantages to an organism. For example, the 
differentiation of fingers and toes in a developing human embryo occurs because 
cells between the fingers undergo apoptosis (15). Necrosis, on the other hand, is 
accidental death of cells, which provokes an inflammatory response (19). 
Apoptosis 
Programmed cell death (PCD) is death of a cell in any form, mediated by an 
intracellular program. The process requires ATP, and no inflammation is induced in 
surrounding tissues due to the fact that the membrane is never disrupted. Autophagic 
cell-death is one type of PCD, characterized by the formation of large vacuoles 
within the cell which eat away organelles in a specific sequence prior to the nucleus 
being destroyed (20). 
Apoptosis is an evolutionarily conserved and highly controlled form of PCD that 
plays a crucial role in development, maintenance of homeostasis, and immunological 
responses in multicellular organisms. Apoptosis involves a series of biochemical 
events eventually leading to cell death. A variety of morphological changes are 
performed, including blebbing, changes to the cell membrane such as loss of 
membrane asymmetry and attachment, cell shrinkage, nuclear fragmentation, 
chromatin condensation, and chromosomal DNA fragmentation. Dysregulation of 
apoptosis is implicated in a range of diseases, including cancer, neurodegenerative 
disorders and autoimmune disease (21). 
The intrinsic and extrinsic pathway 
Cells undergo apoptosis through two major pathways, the intrinsic and the extrinsic 
pathway (15). The extrinsic pathway requires the interaction of death receptors and 
1. Introduction 
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their ligands in the cell membrane, for example the tumour necrosis factor (TNF) 
binding to its receptor TNF-R1, or Fas ligand binding to Fas-receptor. This binding 
initiate the pathway that leads to caspase activation via the intermediate membrane 
proteins TNF receptor-associated death domain (TRADD) and Fas-associated death 
domain protein (FADD); caspases are recruited and activated, resulting in cell death. 
In general, caspases are proteases that cleave their substrates at Aspartate, and have 
cystein in the active site. These caspases can also cleave and activate BH3-
interacting-domain death agonist (BID) enabling it to co-engage the intrinsic pathway 
(22). 
The intrinsic pathway is engaged by cellular stress, for example DNA damage. It is 
controlled by proteins of the B cell lymphoma (Bcl-2) family. Bcl-2 proteins are able 
to promote (Bax/Bim) or inhibit (Bcl-2/Bcl-x) apoptosis as they govern 
mitochondrial outer membrane permeabilization (MOMP), either direct on MAC 
(mitochondrial apoptosis-induced channel) or indirectly through other proteins. 
Cytochrome C is released from mitochondria due to formation of the channel, MAC, 
in the outer mitochondrial membrane, and serves a regulatory function as it precedes 
morphological change associated with apoptosis (23). Once cytochrome C is released 
it binds to apoptotic protease activating factor 1 (Apaf-1) and ATP, which then bind 
to pro-caspase-9 to create a protein complex known as an apoptosome. The 
apoptosome cleaves the pro-caspase to its active form caspase-9, which activates 
caspase-3, leading to apoptosis (22). 
1.3 DNA damage 
During the life of a cell, DNA damage can be induced by environmental or 
endogenous genotoxic insults such as radiation, chemicals, drugs and reactive cellular 
metabolites. DNA damage may lead to mutations, cancer and cellular death. 
1. Introduction 
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1.3.1 DNA damage checkpoints 
Depending on the type of damage, different responses may occur, involving DNA 
damage checkpoint pathways leading to cell cycle inhibition or cell death. The DNA 
damage checkpoints are signal transduction pathways consisting of sensors, 
transducers and effectors. One class of signal transducers is composed of phospho-
inositide kinase (PIK)-related proteins which include ATM (ataxia telangiectasia 
mutated) and ATR (ATM-RAD3-related), regulating the downstream checkpoint 
kinases (CHK) CHK1 and CHK2. The effectors that execute the functions of the 
DNA damage response are substrates of both PIK and CHK, and include proteins 
involved in DNA repair, transcription regulation and cell cycle control, such as the 
Cdk inhibitor p21CIP, breast cancer susceptibility protein-1 (BRCA1) and p53 (24). 
ATM and ATR activation 
In response to double strand breaks (DSB) induced by ionizing radiation (IR), the 
ATM kinase activation is global and rapid whereas the enhanced backup activation of 
ATR is local and delayed (25;26).  
Mutations in the gene that encodes the critical checkpoint-signaling protein kinase 
ATM causes the cancer-predisposing genetic disorder ataxia telangiectasia (A-T) 
(25). When IR causes DSB, the local change in chromatin topology initiates 
autophosphorylation at serine 1981 (Ser1981) on the ATM dimers, dissociating the 
dimeric ATM into monomers competent to bind and phosphorylate their targets, 
amongst them CHK2 and p53 (26). As an effector kinase in response to DSB, CHK1 
is partly redundant with CHK2, but ATR activity is required to keep the downstream 
effector mechanisms (which eventually inhibit DNA replication), poised to respond 
to the acutely activated ATM. In this way, ATR and ATM are both required to the 
complete checkpoint response to IR (16). 
1. Introduction 
 10 
CHK1 and CHK2 
Activation of ATM and ATR activates CHK2 and CHK1 respectively, which in turn 
phosphorylate Cdc25A (CHK2) or Cdc25C (CHK1). In a phosphorylated state, 
Cdc25 associates with the p53 target molecule 14-3-3 and is exported from the 
nucleus, resulting in CDK1 inactivation and establishment of G2 arrest. When 
Cdc25A is phosphorylated, CDK2 phosphorylation is inhibited and the cell is unable 
to initiate DNA replication in S-phase (27). 
1.3.2 The p53 pathway 
In 1979, the tumor suppressor gene p53 was described in a complex with SV40 large 
T antigen, but was initially presumed to be an oncogene. Its character as a tumor 
suppressor gene was finally revealed in 1989, when wild-type p53 was detected (28). 
p53 is a 53 kDa protein with anticancer functions. It plays a role in apoptosis, genetic 
stability, and in inhibition of angiogenesis. Being a nuclear transcription factor, it 
activates the transcription of target genes involved in these processes (28). In normal 
cells the level of p53 is usually low, and it is inactive, bound to the protein murine 
double minute 2 (MDM-2, HDM-2 in humans), which prevents its action and 
promotes its degradation by acting as ubiquitin ligase. In addition to being regulated 
at the level of stability, the activity of p53 can also be post-translationally regulated in 
response to stress signals. Thus, both the N- and C terminal of p53 can be modified 
by phosphorylation, acetylation, O-glycosylation, methylation, ubiquination and 
sumolation (27). 
Structure  
The p53 protein consists of 393 amino acid (aa) residues, divided into five 
structurally and functionally different domains. The acidic amino (N)-terminal end 
consists of the first 42 aa, and is responsible of the transactivating properties of the 
protein. Without this domain, the induction of target genes cannot occur. Interaction 
with MDM-2 also occurs via this domain. 
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Figure 6: The p53 protein. See text for details. 
The central region (aa 101-306) contains the DNA binding domain, and is the site of 
90 % of the p53 mutations found in human cancers. Between these regions, a novel, 
proline rich domain has been identified. The oligomerization domain TET (aa 307-
355) consists of a beta-strand, followed by an alpha-helix necessary for dimerization, 
as p53 is composed of two dimers. A nuclear export signal (NES) is localized in this 
oligomerization domain. The carboxy (C)-terminus of p53 (aa 356-393) contains 
three nuclear localization signals (NLS) and a non-specific DNA binding domain that 
binds to damaged DNA. 
p53 – regulator of cell growth and apoptosis 
Active p53 is induced in response to a myriad of stress types, which include DNA 
damage (induced by radiation or chemical agents), oxidative stress, osmotic shock, 
ribonucleotide depletion and deregulated oncogene expression. Although there are 
multiple DNA damage detection and repair systems in the cell, every type of DNA 
damage is reported to the p53 protein and its pathway. If DNA damage can be 
repaired, p53 activates genes to fix the damage. If the damage cannot be repaired, the 
p53 tumor protein prevents the cell from dividing and signals it to undergo apoptosis 
(27). 
These processes prevent cells with mutated or damaged DNA from dividing, which in 
turn helps to prevent the formation of new mutations and development of tumors. The 
advantage of this arrangement is that one gene can act as an efficient integrator of 
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information about all the different types of stress that can act upon the cell. On the 
other hand, giving one single gene and its products such a crucial role also makes the 
system vulnerable. If the p53 gene is damaged, tumor suppression is severely 
reduced. More than 50 percent of human tumors contain a mutation or deletion of the 
p53 gene (29).  
In unstressed cells, p53 levels are kept low through a continuous degradation of p53. 
MDM-2 binds to p53 and transports it from the nucleus to cytosol where it is 
degraded in proteasomes. Under normal conditions the p53 protein has a half life of 
6-20 min (28). Activation is marked by two major events. Firstly, the half-life of the 
p53 protein is increased drastically, leading to a quick accumulation of p53 in 
stressed cells. Secondly, a conformational change forces p53 to take on an active role 
as a transcription regulator in these cells. The increased concentration and activity of 
the p53 protein leads to transcription of a set of genes that have a p53 response 
element (p53RE) in their promotors (30). 
P53 is an important downstream effector in the DNA damage checkpoint. DNA 
damage causes ATR, ATM, CHK1 or CHK2 to phosphorylate p53 at sites that are 
close to or within the MDM-2-binding region. Phosphorylation of the N-terminal end 
of p53 by the protein kinases disrupts MDM-2-binding (27). Other proteins, such as 
Pin1, are recruited to p53 and induce a conformational change in p53 which prevents 
MDM-2-binding even more. Recently, two other ubiquitin ligases, Coat protein 
complex 1 (COP-1) and Pirh-2, were shown to act upon the stability of the p53 
protein (28;31). 
p53 target genes 
Once activated, p53 leads to expression of several genes. In a negative feedback loop 
MDM-2 is itself induced by the p53 protein. To induce cell cycle arrest, the p21CIP1 
gene is induced. p21CIP1 inhibits Cdk/cyclin complexes that normally phosphorylate 
pRB causing it to dissociate from E2F, thus inhibiting the transcription of S-phase 
genes required for G1/S transition. p53 also induces GADD45 (Growth arrest and 
DNA damage), which is a nuclear protein participating in cell cycle arrest and DNA 
1. Introduction 
repair (32). If DNA repair is not successful, stabilized p53 increases the expression of 
numerous pro-apoptotic genes (BAX, NOXA, PUMA etc) causing damaged cells to 
undergo apoptosis. Recently it has also been revealed that p53 has extra-nuclear 
apoptotic functions independent of transcription. Thus p53 binds the anti-apoptotic 
Bcl-2 proteins (Bcl-2 and Bcl-x) and activates the pro-apoptotic multi domain 
proteins (Bax and Bak) to induce cytochrome C release and subsequent apoptosis 
(33). Cells that have engaged p53-dependent apoptosis typically follow the intrinsic 
pathway, but it is also demonstrated that p53 can promote Fas-mediated (extrinsic) 
apoptosis by increasing the expression of Fas receptor, enabling BID to co-engage 
with the intrinsic pathway (33). 
 
 
 
Figure 7: p53 induces both cell cycle arrest and apoptosis in response to DNA damage. 
p53 has been described as "the guardian of the genome", referring to its role in 
conserving stability by preventing genome mutations (28). Tumor suppressor genes 
are often inactivated in cancer cells, resulting in the loss of normal functions of the 
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cells. Mutations that deactivate p53 in cancer usually occur in the central DNA-
binding core domain. Most of these mutations destroy the ability of the protein to 
bind to its target DNA sequences, and thus prevents transcriptional activation of these 
genes. 
If the p53 gene is damaged, tumor suppression is severely reduced. People who 
inherit only one functional copy of the p53 gene will most likely develop tumors in 
early adulthood, a disease known as Li-Fraumeni syndrome (29).  
1.3.3 DNA damage induction 
DNA damage can be induced by environmental or endogenous genotoxic insults such 
as ionizing or ultraviolet radiation (IR or UV, respectively), chemicals, drugs and 
reactive cellular metabolites. 
Radiation 
Radiation, as used in physics, is energy in the form of waves or moving subatomic 
particles. Radiation can be classified as ionizing or non-ionizing radiation, depending 
on its effect on atomic matter. UV radiation is an example of non-ionizing radiation, 
being electromagnetic radiation with a wavelength shorter than that of visible light, 
but longer than soft X-rays.  
Gamma rays, used in IR, are generally characterized as electro-magnetic radiation 
having the highest frequency and energy, and also the shortest wavelength within the 
electromagnetic spectrum, i.e. high energy photons. Double-strand breaks (DSB) are 
considered the typical form of DNA damage resulting from IR, as one DNA DBS is 
sufficient to trigger apoptosis. A variety of other DNA lesions are also induced, 
among them single-strand breaks, base and sugar damage (27). 
Cytotoxic agents - doxorubicin 
Various cytotoxic agents can be used to induce DNA damage. Most 
chemotherapeutic drugs act by impairing mitosis, effectively targeting fast-dividing 
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cells, or cause cells to undergo apoptosis. Many of the commonly used 
chemotherapeutic drugs can be classified as either alkylating agents, antimetabolites, 
anthracyclines, plant alkaloids or topoisomerase inhibitors, and all of these drugs 
affect cell division or DNA synthesis. The class of anthracyclines includes the 
chemical doxorubicin. Activation of p53, which in turn promotes apoptosis of tumor 
cells, is considered to be a key mechanism of action of doxorubicin (34;35), but it 
also inhibits topoisomerase ІІ, which unwinds DNA for transcription. Doxorubicin 
stabilizes the topoisomerase ІІ complex after it has broken the DNA chain for 
replication, preventing the DNA double helix from being resealed and thereby 
stopping the process of replication (36). Doxorubicin is widely used in chemotherapy 
of cancer. A side effect of doxorubicin-treatment is induction of apoptosis also in 
normal cells. ROS (Reactive oxygen species) generation during intracellular 
metabolism of doxorubicin and subsequent oxidative stress has been proposed to be 
important mechanism(s) for its cardiac toxic side effects (37). 
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1.4 The immune system 
The immune system protects an organism against diseases by identifying and killing 
pathogens and tumour cells. It detects a wide variety of agents, from viruses to 
parasitic worms, and needs to distinguish them from the organism's own healthy cells 
and tissues in order to function properly. Physical barriers like the skin and mucous 
membranes, surface linings of the eyes and the respiratory, urinary, and intestinal 
tracts prevent pathogens such as bacteria and viruses from entering the body. If a 
pathogen breaks these barriers, the innate immune system provides an immediate, but 
non-specific response. However, if pathogens successfully evade the innate response, 
vertebrates possess a third layer of protection, the adaptive immune system. Here, the 
immune system adapts its response during an infection to improve its recognition of 
the pathogen. This improved response is then retained after the pathogen has been 
eliminated, in the form of an immunological memory, and allows the adaptive 
immune system to mount faster and stronger attacks each time this pathogen is 
encountered. As the innate immune system is essential in activating the adaptive 
immune system, the two systems do not function as two separate entities (15). 
An important role of the immune system is to identify and eliminate tumor cells, 
which express antigens not found on normal cells. As the antigens appear foreign to 
the immune system, T cells attack the tumor cells. Tumor antigens are presented on 
major histocompatability complex (MHC) class I molecules in a similar way to viral 
antigens, but as tumor cells often have a reduced number of MHC class I molecules 
on their surface, detection by T cells may be avoided (38). In addition, 
immunological tolerance may develop against tumor antigens, resulting in the 
immune system no longer attacking the tumor cells (39). 
1.4.1 The lymphoid organs 
The immune system includes the primary/central lymphoid organs (the bone marrow 
and the thymus), the secondary/peripheral lymphoid organs (lymph nodes, spleen, 
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mucosa-associated lymphoid tissue (MALT) and gut-associated lymphoid tissue 
(GALT)), and circulating immune cells. The immune cells are generated and 
developed in the primary lymphoid organs, whilst the secondary lymphoid organs are 
the major sites of immune activation (15). 
 
Figure 8: Schematic illustration of the immune system (15). The bone marrow 
and the thymus are the central lymphoid organs (shown in yellow), while the 
peripheral lymphoid organs (lymph nodes, spleen, MALT and GALT) are shown in 
blue. Lymphatic vessels drain fluid (lymph) containing antigen from the tissues 
through the lymph nodes where the antigen is trapped to interact with T cells. 
 
1.4.2 The adaptive immune defense 
The cells of the adaptive immune system are special types of leukocytes, called 
lymphocytes (primarily B cells and T cells), and the lymphocytes are derived from 
haematopoietic stem cells in the bone marrow. B cells are involved in the antibody 
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response, whereas T cells are involved in cell-mediated immune response. After 
microbes are engulfed by dendritic cells of the innate immune system, they are 
presented at the surface together with MHC. The dendritic cells will migrate to a 
nearby lymphoid organ where they present the agents to T cells. Some T cells then 
migrate to the site of infection where they destroy the microbes, while others remain 
in the lymphoid organ to activate B cells. B cells secrete antibodies that circulate in 
the body, coating the microbes and targeting them for efficient phagocytosis. Some B 
cells are stimulated to multiply and differentiate into memory cells to be able to react 
to the same antigen later in a system called secondary immune response, or 
immunological memory (15). 
B cells and T cells are generated in the bone marrow in adults, and while B cells also 
develop and mature here, T cells migrate to the thymus in order to develop. Both cell 
types rearrange their receptors, and when T cell receptor is expressed at the surface of 
T cells, it is subjected to negative and positive selection before they exit as naïve T 
cells into the blood stream. B cells express IgM before negative selection, where 
potentially autoreactive cells are eliminated before completing development with 
expression of IgD, CD19 and CD38. When these matured, naïve B cells leave the 
bone marrow for the periphery; they can undergo activation and differentiation 
towards plasma cells or differentiate towards memory B cells. T cells are activated by 
foreign antigen to proliferate and differentiate into effector cells, termed T-helper 
(Th) 1 cells and Th2 cells. These cells activate macrophages and B cells, respectively. 
B cells can be activated by antigens with or without help from Th2 cells. Before 
activation both B and T cells are in the resting phase G0 in peripheral blood or 
lymphoid organ (15), and in this state T cells are very resistant to apoptosis.  
In vitro, T cell activation can be mimicked by antibodies, and T cell receptor 
activation can be bypassed by using chemicals such as 12-0-tetradecanoylphorbol 13-
acetate (TPA), or by lectins such as phytohemagglutinin (PHA). TPA activates PKC, 
whereas PHA crosslink surface receptors (40) resulting in activation of T cells. In B 
cells, this activation can be mimicked in vitro by stimulating the B cells with anti-
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immunoglobulin or various lectins known to crosslink the surface immunoglobulin. 
Staphylococcus Aureus Cowan (SAC) is a crude bacterial cell suspension that 
activates B cells via lectins at the bacterial surface (41). Memory B cells can persist 
for decades after initial activation, whereas when T cells are activated, they become 
more susceptible to die. This is because T cells are destined to die at some point 
either because they are not needed, or they must be deleted if they are repeatedly 
activated by self-antigen. The former process occurs through the intrinsic pathway 
and has been termed activated T cell autonomous death (ACAD), whereas the latter is 
called activation-induced cell death (AICD), and is to a large extend mediated by the 
death receptor pathway (42). 
1.4.3 Epstein-Barr virus 
Epstein-Barr virus is a double stranded DNA virus genome of 172 kb. It belongs to 
the γ herpes virus family, and was the first candidate of human tumor virus, identified 
in 1964. It targets lymphoid cells, mainly B cells, but is also known to infect other 
cells, like epithelial cell. The EBV virus has a unique ability to transform resting B 
cells into permanent, latently infected lymphoblastoid cell lines, and persist in resting 
nonproliferating memory cells. There is a delicate balance between the virus and the 
host immune system, where disruption of the balance may lead to the development of 
EBV-associated disease like mononucleosis, lymphoproliferative disease or Burkitt’s 
lymphoma. Although 90 % of the human population is infected, the EBV virus 
generally persists in a host for life without causing disease (43). 
1.5 Vitamin A and the immune system 
Vitamin A plays an important role in the immune system to protect against infection, 
and deficiency of this vitamin affects more than 100 million children throughout the 
world (2;44-46). Approximately 250 000 to 500 000 malnourished children in 
developing countries become blind each year, and each year more than one million 
childhood deaths are associated with vitamin A deficiency (VAD), mainly infectious 
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diseases (47). VAD significantly impairs the mucosal epithelial barriers in the eye, 
respiratory, gastrointestinal and urogenital tracts, and it has been demonstrated that 
deficiency affect the innate immune system by enhancing macrophage-mediated 
inflammation, but impairing their ability to ingest and kill bacteria (48). Hence, it 
may lead to increased pathogen replication, increased pathology, inflammation and 
secondary immune responses (49). On the other hand, a too large intake of this fat-
soluble vitamin can result in acute or chronic toxicity (4). 
1.5.1 Regulation of B cells and T cells by Vitamin A 
The reported effects of VAD on immunity in human populations can be difficult to 
interpret due to concurrent effects of protein-energy malnutrition (PEM) and 
infections, but by animal studies it is possible to bypass some of these obstacles. 
Beneficial effects of retinoids on antibody responses in animal studies are generally 
reflected also in human studies (49;50). Semba and coworkers found that children 
with mild VAD had relative lower IgG responses to tetanus immunization than 
children who had been supplemented to normal vitamin A levels, and later the same 
group concluded that vitamin A intervention enhanced the relevant humoral 
responses in terms of the IgG1 subclass (50). VAD has been associated with impaired 
mucosal immunity due to selective loss of IgA producing cells (51), and RA has, in 
the presence of IL-5, the ability to induce isotype switching to IgA (51;52). It has 
been demonstrated that dendritic cells (DC) from GALT were able to induce IgA-
secretion in murine B cells, concomitant with induction of gut-homing receptors at 
the B cell surface. The GALT-derived DC are known to express the enzymes 
required to convert dietary vitamin A to retinoic acid (53;54), and the IgA-secretion 
induced by RA was shown to require cooperation with GALT-DC-derived IL-5 or 
IL-6 (54).  
In vitro, our group have demonstrated that physiological as well as pharmacological 
doses of RA inhibits mature B cell proliferation as well as growth of B cell precursors 
(55;56), and we have demonstrated that this inhibition by RA is because RA prevent 
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phosphorylation of pRB, due to an up regulated level of the CKI p21CIP at the level of 
transcription (57). Recently, however, our group could show that whereas naïve cells 
are inhibited by RA, memory B cells stimulated via toll like receptor (TLR) 9 are 
stimulated (58). We have also demonstrated that RA treatment of normal B cells can 
inhibit spontaneous apoptosis (59). 
In addition to affecting antibody responses, VAD also changes the pattern of 
Th1/Th2 cytokine production in animal studies (49). It seems clear that vitamin A is 
an important regulator of the Th1/Th2 balance in the immune system, as VAD skews 
the Th1/Th2-balance in a Th1-direction (49).In vitro, a number of studies has shown 
conflicting data as to whether RA enhanced, reduced or had no effect on lymphoid 
proliferation (60-62). This inconsistency may be due to the use of different 
concentrations of RA; high concentrations of RA (above 10 µM) were inhibitory, 
whereas lower concentrations (0.1-1 µM) were stimulatory on PHA-mediated 
proliferation (63). Most reports indicate, however, that vitamin A stimulates T cells 
(62-64). Our lab has demonstrated that RA enhances the proliferation of human T 
cells by stimulating the production of IL-2 (65) and we have also shown that RA 
protects normal T cells from apoptosis due to enhanced secretion of IL-2 (66). 
1.5.2 Recommendations for intake of vitamin A 
Norwegian recommendations for intake of vitamin A are provided by Sosial og 
helsedirektoratet, based on The Nordic Nutrition Recommendations (NNR). Different 
forms of vitamin A are metabolized to different quantities of retinol, and the 
recommendations are therefore given as retinol activity equivalent (RAE). One RAE 
is equal to either 1 µg ROH, 12 µg β-carotene, 24 µg α-carotene or 24 µg 
cryptoxanthin (4;67). 
The NNR is guidelines for the nutritional composition of a diet which provides a 
basis for good health, based on the current nutritional situation in the Nordic 
countries. To prevent deficiency but also avoid toxicity, a lower and upper level of 
intake is established. In addition, an intake level (RI) is recommended to maintain 
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good nutritional status among practically all healthy individuals. RI is based on an 
average requirement, and is 900 RAE for men, and 700 RAE for women, unless the 
woman is pregnant or lactating in which case the RI is higher; 800 and 1100 RAE 
respectively. The Upper Intake Level (UL) for vitamin A is the maximum daily 
intake unlikely to result in adverse health effects, and is set to 3000 µg of preformed 
vitamin A for both men and women, as toxic effects primarily have been linked to 
ROH or RE. The Lower intake level (LI) of vitamin A is defined as an intake below a 
level that can lead to deficiency symptoms in some individuals. The LI for women is 
400 RAE and 500 RAE for men (68). 
Vitamin A deficiency diminishes the ability to fight infections, but also mild degree 
of VAD may increase children's risk of developing respiratory and diarrheal 
infections, decrease growth rate, slow bone development, and decrease likelihood of 
survival from serious illnesses (44;46;49). Xerophthalamia is an ocular disease 
caused by VAD, often associated with a concurrent or recent history of infection like 
diarrhea, pneumonia or measles (49). It has been reported that vitamin A supplements 
have failed to improve vitamin A status after various infections, and animal studies 
have shown that vitamin A stores are depleted after acute viral infection, indicating 
that severe or recurrent infections can lead to serious VAD (49). 
Severe zinc deficiency often accompanies VAD, associated with strict dietary 
limitations or anorexia. Zinc is required to produce RBP, and therefore a deficiency 
in zinc limits the body's ability to transport vitamin A from stores in the liver to body 
tissues (67). In addition, the level of the transport protein RBP can be lower than 
normal during disease due to impaired tubular reabsorption of low-molecular weight 
proteins like RBP, leading to a higher loss of retinol through urine (49). Iron 
deficiency can also affect vitamin A metabolism, and iron supplements provided to 
iron-deficient individuals may improve body stores of vitamin A (67). In a interesting 
recent study it was suggested that high intake of vitamin A in childhood in industrial 
countries may be the cause of the high incidence of asthma in this part of the world 
(69). This is due to the skewing of the immune response to Th2- with IgA responses. 
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1.6 Cancer and cancer treatment 
Malignant tumors are characterized by deregulated cell growth and apoptosis, and 
their ability to invade and destroy adjacent tissues. Malignant tumors may also spread 
to other locations in the body (metastasise). All cancers are caused by DNA 
mutations due to DNA damaging agents (tobacco smoke, radiation, chemicals, or 
infectious agents) or through errors in DNA replication (15). Lymphoma is the 
general term for a group of cancers that originates from cells in the lymphatic system, 
and it is the result of a lymphocyte undergoing a malignant change and multiplying, 
eventually crowding out healthy cells and creating tumors which enlarge the lymph 
nodes or other sites in the body. Non-Hodgkin lymphoma represents a diverse group 
of cancers, with the distinctions between types based on the characteristics of the 
cancerous cells. Hodgkin lymphoma is a specialized form of lymphoma, with 
characteristics that distinguish it from all other cancers of the lymphatic system: 
including the presence of an abnormal cell called the Reed-Sternberg cell (a large, 
malignant cell found in Hodgkin lymphoma tissues). Malignant cells originating from 
lymphoid precursors in the bone marrow are called leukemia, and occasionally also 
lymphoma cells will leave the solid tumors and populate the blood or lymph as 
leukemia. 
There are several strategies for treating cancer, such as surgery, chemotherapy, 
radiation therapy and immunotherapy, and often several treatments are combined. 
Many of the treatment strategies depend on DNA damage responses to kill cancer 
cells. Inducing DNA damage in dividing cells is an efficient way of killing cancer 
cells, although a side effect is that also rapidly dividing normal cells are affected by 
the treatment.  
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1.6.1 Vitamin A and cancer treatment 
From the early 1900s, vitamin A deficiency has been suggested to be associated with 
tumor development, and the anticancer activity of RA and other retinoids has been 
demonstrated in animal cancer models (46). RA can both induce the differentiation of 
undifferentiated stem cells, and inhibit the proliferation of activated or transformed 
cells, and a lot of effort has been put in research to use RA in prevention and 
treatment  human cancers (70). The M3 subtype of acute myeloid leukemia (AML), 
also known as acute promyelocytic leukemia (APL), is almost universally treated 
with atRA in addition to chemotherapy. APL is characterized by a chromosomal 
translocation (t [15; 17]), involving a fusion between the RARα gene and a 
previously unknown locus named promyelocytic leukemia (PML). A consequence of 
this gene rearrangement is expression of the PML-RARα chimeric oncoprotein, 
which is responsible for the cellular transformation as well as the RA response 
observed in APL (71). 
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2. Aims of the study 
A major problem with conventional cancer therapy is that only a subgroup of patients 
responds to a given treatment, and the side effects are often the limitation for the dose 
efficiency of the treatment. DNA damage responses are the basis for common anti-
cancer treatments like irradiation and chemotherapy (24;25;34;36). In order to 
increase the number of patients that respond to a given treatment, and to increase the 
therapeutic index, there is a constant search for modulators of DNA damage 
responses as targets in cancer therapy. 
We have previously demonstrated that elevation of intracellular cAMP in fibroblasts 
and lymphoid cells lead to inhibition of DNA-replication, and in the same paper we 
demonstrated that the reduced DNA replication resulted in inhibition of DNA 
damage-induced apoptosis (72). Based on our previous demonstrations that RA has 
profound effects on proliferation of various populations of human B- and T cells, we 
anticipated that RA also might modulate DNA damage responses in these cells. The 
tumor suppressor p53 is an important downstream mediator of DNA damage 
responses (27;28). Thus upon DNA damage, p53 will be stabilized and activated and 
thereby induce transcription of a number of genes involved in growth arrest, DNA 
repair and apoptosis (31).  
The overall purpose of the present study is to determine if retinoic acid can be a 
modulator of DNA damage responses in lymphoid cells. The specific aims are: 
1. Reveal the effects of RA on DNA damage-induced apoptosis in 
I. normal B cells 
II. EBV-transformed B cells 
III. normal T cells 
2. Elucidate the effects of RA on regulation of p53 expression upon induction 
of DNA damage in lymphoid cells 
3. Materials and methods 
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3. Materials and methods 
Materials 
Chemical 
[3H] thymidine (1000mCi/ml) 
Acidic acid 
Acrylamide/Bis 
Ammonium persulfate (APS) 
Aprotinin 
Bio-Rad Protein assay dye 
Bromphenol Blue 
Doxorubicin (3.45 mM) 
ECL+ Western blotting detection kit 
EDTA (1 mM) 
Ethanol 
Fetal Bovine serum FBS 
Forskolin (20mM) 
Gamma-globulin 
Glycerol 
Glycine 
HCl 
Leupeptine 
L-Glutamine 
LymphoprepTM 
Methanol 
MicroscintTM 
Molecular weight standard 
Non-fat dried milk 
Penicillin Streptomycin 
PHA (2 mg/ml) 
Producer 
Amersham Biosciences 
Merck 
Sigma 
Shelton scientific 
Sigma 
Bio-Rad 
Bio-Rad 
Sigma 
Amersham Biosciences 
Prolabo 
Arcus 
Gibco 
Calbiochem 
Sigma 
Prolabo 
Sigma 
Merck 
Sigma 
Gibco 
Fresenius Kabi Norge 
BDH 
Packard 
Bio-Rad 
Nestlé Molico 
Gibco 
Sigma 
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PMSF 
Ponceau S 
Propidium Iodide (1,5 mM) 
Retinoic acid, all-trans (3.3 mM) 
RPMI 1640 medium 
SAC (10 %) 
Sodium Azide (NaN3) 
Sodium Chloride (NaCl) 
Sodium dihydrogenphosphate(NaH2PO4) 
Sodium deoxycholate (C24H39NaO4) 
Sodium dodecyl sulphate (SDS) 
Sodium Fluoride (NaF) 
Sodium orthovanadate (Na3VO4) 
TEMED 
TPA (10-3 M) 
Tris Hcl 
Triton X-100 
Tween 20 
β-mercaptoethanol 
β-glycerophosphate 
 
Equipment 
Bio-Rad Mini Protean П gel apparatus 
Buffy coat 
Cell culture flasks 
Cell culture plates (6,12,24 and 96-wells) 
Biofuge fresco table top centrifuge 
Sigma 4K15 centrifuge 
Beckman J2-21 centrifuge 
CO2 incubator 
Coulter® Microdiff 18 (Cell counter) 
Cryo tubes 
Sigma 
Sigma 
Sigma 
Department of nutrition 
Gibco 
Sigma 
Merck 
BDH labratories 
Prolabo 
Sigma 
Sigma 
Merck 
Sigma 
Bio-Rad 
Sigma 
Angus Buffers & Biochemicals 
Sigma 
Sigma 
Sigma 
Sigma 
 
 
Bio-Rad 
Ullevål University Hospital 
Costat 
Cellstar 
Haraeus 
Sigma 
Beckman 
NuaireTM 
Dan Meszantsky 
Cell star 
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Eppendorf tubes (micro-tubes 1.5 ml) 
FACSCalibur (Flowcytometer) 
Falcon tubes (15 and 50 ml) 
Film cassette 
Filtermate 196 harvester 
Gamma-cell®3000 Elan (Irradiator) 
Heating block 
Hybond ECLTMNitrocellulose membrane 
HyperfilmTM 
Kodak X-omat 1000 processor 
MACS® LS Separation Column 
MACS® Separator magnet 
Magnet for cell culture flask 
Magnetic stirrer 
MicroscintTM 
Microlitre glass syringe (Hamilton) 
Penicillin Streptomycin 
Plastic wrap 
Platform shaker 
Rock-n-roller 
Rotator mixer 
Semimicro disposable cuvettes (1.5 ml) 
Sterile scissors 
TopCountTM 
Transblot®SD-semi dry transfer cell 
Ultrospec 3100 pro spectrophotometer 
Unifilter®-96, GF/C® 
Versi-dryTMProtective paper 
Vortexer 
Water bath 
Whatman chromatography paper 3 MM 
Axygen Sientific 
Becton Dickinson 
Becton Dickinson 
Kodak 
Packard 
MDS Nordion 
Dan Meszantsky 
Amersham Bioscience 
Amersham Bioscience 
Kodak 
Miltenyi Biotech 
Miltenyi Biotech 
Self-made 
Framo Gerätetechnik 
Packard 
Kebolab 
Gibco 
Andvord 
Edmund Blücher 
Labinco 
Stuart Scientific 
Plastibrand 
Rocket Medical 
Packard 
Bio-Rad 
Amersham Biosciences 
Laborel 
Nalgene 
Heidolph 
Julabo 
Whatman 
  
3. Materials and methods 
 29  
 
Antibodies 
Anti actin primary antibody (C-2) 
Anti p53 primary antibody (DO-1) 
Goat-anti mouse IgG 
DETACHaBEAD®CD19 
Dynabeads® CD19 (Pan-B) 
MACS® CD4 MicroBeads 
 
 
Sigma 
Sigma 
Bio-Rad 
Dynal 
Dynal 
Miltenyi Biotech 
Stock solutions 
RPMI/PS medium 
480 ml RPMI 1640 medium 
10 ml PS 
10 ml glutathione 
 
 
 
0.01 M EDTA in RPMI/ PS medium 
490 ml RPMI/PS medium 
10 ml EDTA (1 mM) 
 
 
 
10 % FBS in RPMI/ PS medium 
450 ml RPMI/PS medium 
50 ml FBS 
 
 
 
1 % FBS in PBS 
9.9 ml PBS 
100 µl FBS 
 
 
 
0.5 % FBS/ 2 mM EDTA in PBS 
198 ml PBS 
1 ml FBS 
0.8 ml EDTA (1 mM) 
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PBS (20 x) 
4.8 g KH2PO4  
28.8 NaH2PO4   
4 g KCl 
160 g NaCl 
800 ml H2O 
Adjust pH to 7.4. Distilled water to 1 l. The buffer is stored at 4-8ºC. 
 
 
 
 
TBS-Tween: 
24.2 g Tris 
80 g NaCl 
0.1% Tween 20  
Distilled water to 10 litre, pH is adjusted to 7.6 with HCl 
 
 
 
Primary antibody solution p53 : 
1 µg/ml anti p53 antibody in 5 % milk with TBS-Tween  
0.03 % NaN3  
 
Primary antibody solution actin: 
1 µg/ml anti actin antibody in 0.5 % milk with TBS-Tween 
0.03 % NaN3  
 
Secondary  antibody solution: 
Goat Anti-Mouse IgG HRP (1:4000) in 2 % milk with TBS-Tween 
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Doxorubicin 
Doxorubicin (3.45 mM) in RPMI/PS medium 
 
 
Forskolin 
 Forskolin (20 mM) in RPMI/ PS medium containing 10 % FBS 
 
PHA 
PHA (2 mg/ml) in RPMI/ PS medium containing 10 % FBS 
 
 
Retinoic acid (RA) 
All-trans Retinoic acid (3.3 mM) in RPMI/ PS medium containing 10 % FBS 
 
 
SAC 
SAC (10 %) in RPMI/ PS medium containing 10 % FBS 
 
 
TPA 
TPA (10-3 M) in RPMI/ PS medium containing 10 % FBS 
 
 
[3H] thymidine 
[3H] thymidine (1000mCi/ml) in RPMI/ PS medium  
 
 31  
3. Materials and methods 
 32 
3.1 General techniques for culturing cells 
To avoid contamination of microorganisms, all solutions and equipment that are in 
contact with the cells are autoclaved, and as an extra precaution, antibiotics are 
included in the culture medium to prevent bacterial growth. Gloves treated with 
ethanol are worn while handling the cells. To simulate an in vivo situation, the cells 
are cultured in an incubator at 37˚C, with 5 % CO2 and humidified air. 
3.1.1 Culturing of EBV cells 
The lymphoid cell line EBV is cultured in 10 % fetal bovine serum (FBS) in 
complete RPMI medium containing inorganic salts, amino acids, vitamins, glucose, 
glutathione and pH-indicator, and growth factors that all cells need to grow and 
proliferate. To prevent contamination and to avoid glutathione loss due to a short 
half-time, penicillin and glutathione are added to the RPMI medium. 
The cell cultures are diluted every 2-3 day to keep the density between 0.1-1.5 x 106 
cells/ml, as the cells have a doubling time of 24 hours (h). 
3.1.2 Culturing of B- and T cells 
Freshly isolated lymphoid cells are cultured in RPMI medium containing 10 % FBS. 
B cells are cultured at a density of 1.5 x 106 cells/ml, whereas T cells are cultured at a 
density of 2 x 106 cells/ml. 
3.2 Isolation of lymphocytes 
Lymphocytes are isolated from buffycoats. Buffycoats are end products from blood 
after erythrocytes and plasma is removed. The buffycoats are derived from volunteer 
blood donors at Ullevål University Hospital. 
3. Materials and methods 
3.2.1 Isolation of  B cells 
All B cells, except plasma cells, express the CD19 antigen on the surface (73). 
Positive selection by the use of magnetic beads coupled to CD19 antibody 
(Dynabeads® CD19 (Pan-B)) is used to isolate B cells from buffycoats, as the 
antibodies have high affinity to the antigen. To separate the cells from the 
Dynabeads, two different methods are available; one which allow the cells to detach 
over night, the other method using DETACHaBEAD®CD19. 
DETACHaBEAD®CD19 are beads coated with polyclonal antibody produced by 
immunising sheep with Fab fragments of mouse immunoglobulin. 
DETACHaBEAD®CD19 detaches B cells that have been positively selected using 
Dynabeads® CD19 (Pan-B). This method is considered a gentle way of removing the 
beads from the isolated B cells, providing cells with >99% purity and >98% viability. 
Typically 10-40 x 106 B cells are isolated from one buffycoat. 
 
 
 
Figure 9: Isolation of B cells by the use of CD19 Dynabeads. B cells are 
isolated by letting CD19 beads adhere to the cells, followed by using a magnet 
to separate CD19- positive and -negative cells. 
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Equipment and solutions: 
Versi-dryTM protective paper                  
Buffycoat 
Sterile scissors 
Cell culture flask  75 cm2 
Dynabeads® CD19 (Pan-B) 
DETACHaBEAD®CD19 
Eppendorf tubes 
15 ml Falcon tubes  
Rotator mixer 
 
Magnet for eppendorf tubes  
Magnet for cell culture flasks  
RPMI/ PS medium 
0.01 M EDTA in RPMI/ PS medium 
10 % FBS in RPMI/ PS medium 
1 % FBS in PBS 
CO2 incubator (NuaireTM) 
Cell counter (Coulter® Microdiff 18) 
Rock-n-roller 
 
Procedure: 
1. Isolation of B cells by the use of Dynabeads® CD19 and overnight detachment 
The blood from the buffycoat is drained into a 75 cm2 flask containing 25 ml RPMI 
medium with penicillin and streptomycin (PS) and 0.01 M EDTA. 350 µl 
Dynabeads® CD19 (Pan-B) is added, and to let the B cells bind to the CD19 antibody 
on the beads, the flask is put to rotate at 4˚C for about 40 minutes (min). After 
rotation, the blood is separated from the CD19 beads by letting the beads adhere to a 
magnet. The blood is removed, and the B cell-bound beads are washed 6 times with 
RPMI/PS before they are resuspended in 20 ml medium containing 10 % FBS, and 
left over night in a humidified CO2 incubator. The beads are then removed by a 
magnet, and the cells are subjected to centrifugation at 500 x g for 10 min at 4ºC. The 
pellet is resuspended in 2 ml medium containing 10 % FBS, and the cells are counted 
by the use of Coulter® Microdiff 18 cell counter according to the manufacturer’s 
manual. 
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2. Removing beads by the use of DETACHaBEAD®CD19 
The cells are isolated by the use of Dynabeads® CD19 (Pan-B) as described in the 
previous section, but instead of leaving the cells in a CO2 incubator over night in 20 
ml medium containing 10 % FBS, the final pellet is resuspended in 200 µl medium 
containing 10 % FBS. 200 µl DETACHaBEAD®CD19 is added, and after 45 min of 
incubation on a rock-n-roller, the tube is put on a magnet rack for 1.5 min. The 
supernatant is transferred to a Falcon tube, and to make sure all the beads have been 
removed, the cells are washed three times with PBS containing 1 % FBS. After 
collecting the cells by centrifugation at 300 x g for 10 min, the cells are washed two 
more times before resuspended in medium containing 10% FBS. The cells are 
counted by the use of Coulter® Microdiff 18 cell counter, and the cells are kept in a 
humidified CO2 incubator for further use. 
3.2.2 Isolation of T cells 
Isolation of T cells from buffycoat is performed by a two-step procedure. In the first 
step, lymphocytes are isolated by density centrifugation using LymphoprepTM, and in 
the second step, T cells are positively isolated by magnetic beads conjugated to 
monoclonal anti-human CD4 antibodies. Typically 50-100 x 106 CD4+ T cells are 
isolated from one buffycoat. 
1. LymphoprepTM separation 
LymphoprepTM contains sodium-metrizoat and polysaccharides, and therefore has 
higher density than lymphocytes. Due to the density distinction, blood cells are 
separated during centrifugation, placing cells with the highest density at the bottom of 
the tube i.e. erythrocytes and granulocytes. Due to its lower density, lymphocytes will 
accumulate as a layer on top of the LymphoprepTM. 
3. Materials and methods 
 
Figure 10: Separation of lymphocytes. See text for details. 
 
2. Isolation of T cells by the use of CD4 antibodies 
 CD4 is an accessory molecule involved in the recognition of MHC class II/peptide 
complexes by the TCR heterodimers, and it is expressed on T helper cells and at a 
lower level on monocytes and dendritic cells. CD4 is expressed on most thymocytes 
and about 65% of all peripheral blood T cells. After letting the lymphocytes adhere to 
CD4 MicroBeads, the CD4+ cells are separated from the negative cells by the use of a 
LS MACS® Separation Column and a MACS® Separator magnet. Thus, after removal 
of the column from the magnetic field, the magnetically retained CD4+ cells can be 
eluted as the positively selected cell fraction. 
Equipment and solutions: 
Versi-dry TM protective paper                  
Buffycoat   
Sterile scissors 
Cell culture flask  75 cm2 
Lymphoprep TM 
50 ml Falcon tubes 
Rotator mixer  
Cell counter (Coulter® Microdiff 18) 
 
RPMI/ PS medium 
0.01 M EDTA in RPMI/ PS medium 
0.5 % FBS/ 2 mM EDTA in PBS 
10 % FBS in RPMI/ PS medium 
MACS® CD4 MicroBeads 
LS MACS® Separation Column 
MACS® Separator magnet 
 CO2 incubator (NuaireTM)  
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Procedure: 
The blood is mixed with 160 ml 0.01 M EDTA solution in a 75 cm2 flask, followed 
by carefully distribution into 50 ml tubes each containing 15 ml LymphoprepTM. The 
tubes are subjected to centrifugation at 800 x g for 20 min at room temperature (RT). 
The layers of lymphocytes are aspirated and transferred to new 50 ml Falcon tubes 
before centrifugation at 300 x g for 15 min at 4˚C. To remove the layer of platelets on 
top of the lymphocytes the tubes are carefully inverted, as the platelets then loosen 
and can be removed. After washing the remaining cells, the pellet is resuspended in 
10 ml medium containing 10 % FBS and the cells are counted by the use of Coulter® 
Microdiff 18 cell counter. After centrifugation at 300 x g for 10 min at room 
temperature, the cell pellet is resuspended in 1280 µl PBS containing 0.5 % FBS and 
2 mM EDTA. Before incubation for 15 min at 4-8˚C, 320 µl MACS® CD4 
MicroBeads are added. 25 ml PBS containing 0.5 % FBS and 2 mM EDTA is added 
before centrifugation at 300 x g for 10 min at 4˚C and the pellet is resuspended in 800 
µl PBS containing 0.5 % FBS and 2 mM EDTA. A LS MACS® Separation Column is 
placed on the magnetic field and the column is calibrated with 3 ml PBS containing 
0.5 % FBS and 2 mM EDTA before cells are added. The column is washed 3 times in 
3 ml PBS containing 0.5 % FBS and 2 mM EDTA, before 5 ml of the same solution 
is pressed through the column with the stamp and the cells are collected in a 15 ml 
Falcon tube. The cells are subjected to centrifugation for 10 min at 300 x g and 
resuspended in 2 ml medium containing 10 % FBS before the cells are counted in a 
Coulter® Microdiff 18 cell counter. The cells are kept in a humidified CO2 incubator 
for further use.  
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Figure 11: Isolation of CD4+ T cells. MACS® CD4 MicroBeads are added 
to the lymphocyte fraction, positively selecting CD4+ T cells. A LS 
MACS® Separation Column is placed on the magnetic field and buffer is 
pressed through the column with the stamp collecting the CD4+ T cells. 
3.3 Analysis of cell proliferation 
Different methods can be used to assess proliferation. The number of cells can be 
directly measured by using a Bürcker chamber or a cell counter. Alternatively, 
proliferation can be indirectly measured by analyzing DNA synthesis. 
3.3.1 Cell counting 
An automatic cell counter (Coulter® Microdiff 18) determines the cell concentration 
by detecting and measuring changes in electrical resistance when a particle in a 
conductive liquid phase passes through a small aperture. As each cell goes through 
the aperture, it disrupts the current and causes a measurable pulse. The number of 
pulses equals the numbers of cells. 
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3.3.2 Measuring DNA synthesis 
Cells incorporate thymidine into DNA when they are in S-phase, and uptake of radio-
labelled thymidine can then be used to assess the percentage of cells in S-phase. 
Since cells in S-phase usually proceed to mitosis and divide, measuring uptake of 
radio-labelled thymidine in cells gives a good estimation of the extent of 
proliferation. 
Equipment and solutions: 
96 well culture plate 
10 % FBS in RPMI/PS 
Unifilter®-96, GF/C® 
MicroscintTM 
 
[3H] thymidine in RPMI solution 
Packard filtermate 196 harvester 
Scintillation counter (Packard TopCountTM)  
CO2 incubator (NuaireTM) 
 
Procedure:  
Medium and stimulants are distributed in a 96 well plate before the cells are added to 
each well to a total volume of 200 µl. After incubation for 72 h, 50 µl of the [3H] 
thymidine solution is added to the wells, and the cells are incubated for another 24 h. 
The cells are then harvested onto a filter by using a cell harvester and according to the 
manufacturer’s manual. DNA synthesis is measured in the scintillation counter 
Packard TopCountTM. 
3.4 Induction of DNA damage  
Double strand DNA damage can be induced in different ways. We have used two 
different methods, γ-irradiation and chemotherapeutic agents, respectively. 
3.4.1  γ –irradiation of cells 
To induce double strand breaks the cells are exposed to ionizing radiation (IR). When 
IR causes double strand breaks (DSB), the local change in chromatin topology initiate 
3. Materials and methods 
autophosphorylation at serine 1981 (Ser1981) of the ATM dimers, dissociating the 
dimeric ATM into monomers competent to bind and phosphorylate their targets, 
amongst them CHK2 and p53. IR is induced by radiation from a 137 Cs source. 
 
Equipment and solutions: 
Gamma-cell® 3000 Elan irradiator 
15 ml Falcon tubes 
 
12-well culture plate 
CO2 incubator (NuaireTM) 
Procedure: 
The EBV, B or T cells (0.7-2 x 106 cells/ml) are exposed to 10 Gray (Gy) in the 137 
Cs Gamma-cell® 3000 Elan-apparatus, each sample in a 15 ml Falcon tube. Following 
γ-irradiation, 0.5-1 ml of each sample is transferred to a 12-well culture plate, before 
the cells are incubated for 18-20 h in a humidified CO2 incubator (Nuaire TM). 
3.5 Cell death 
3.5.1 PI staining of cells 
To distinguish between dead and viable cells, the DNA-binding dye propidium iodide 
(PI) can be used. Viable and early apoptotic cells exclude PI due to an intact cell 
membrane, whereas necrotic and apoptotic cells with leaky membranes take up PI 
and will stain the DNA. PI-staining of the cells is detected as red fluorescence in a 
flow cytometer equipped with an argon laser. 
Equipment and solutions: 
Cryo tubes 
Propidium iodide  (1.5 mM) in dH2O  
FACSCalibur (Flow cytometer) 
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Procedure: 
All handling of PI should be done under protection from light. 
Cells are transferred to polystyrene round bottom tubes, PI is added to a final 
concentration of 20 µg/ml, and the tubes are kept dark in room temperature for 10 
min. By using the flow cytometer according to the manufacturers’ manual, the 
samples can be analysed for red fluorescence (PI-staining). 
3.5.2 Scatter analysis 
A fluorescence activated cell sorter (FACS) can be used to measure the distribution 
of viable and dead cells. FACS analyses are based on optical properties of single cells 
passing through a focused laser beam. As the cells pass through the laser beam, they 
disrupt and scatter the laser light, detected as forward- and side scatter (FSC and SSC 
respectively). The side scatter is an indicator of the cell’s granularity, whereas the 
forward scatter is related to cell size. Combined, these parameters can distinguish 
viable cells from apoptotic or necrotic cells. Apoptotic cells are smaller and more 
granular than viable cells due to shrinkage of the cells, chromatin condensation, 
fragmentation of nuclei and the formation of apoptotic bodies. Necrotic cells will be 
larger than viable cells due to swelling. Analysis of five hundred cells counted per 
second, with a total of 10 000 cell counted from each sample provides a statistically 
significant picture of the physical and biochemical state of the sample. The 
flowcytometer is used according to the manufacturer’s manual. 
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Figure 13: Flow cytometry, FACSCalibur. Single cells pass through a focused 
laser beam, and as they pass through the laser beam, they disrupt and scatter the laser 
light, detected as forward- and side scatter Picture from manufacturer’s manual. 
3.6 Analysis of protein expression by Western Blot 
Western blot analysis detects and quantifies specific proteins in a sample of tissue 
homogenate or extract. After the protein samples are solubilised by the use of 
detergents, it is denatured by boiling. Following separation of the proteins by 
electrophoresis on a polyacrylamide gel, the proteins are transferred from the gel and 
onto a nitrocellulose membrane where they are hybridised using antibodies specific to 
the antigenetic epitopes of the protein. By adding a secondary antibody conjugated to 
horseradish peroxidase (HRP) that catalysis the oxidation of lumniol, the primary 
antibody bound to the specific protein can be detected by chemiluminescence and 
autoradiography. 
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3.6.1 Preparation of cell lysates for electrophoresis 
The purpose of the lysis is to solubilize all of the target antigens in a form that is 
immunoreactive and undegraded. Several methods of solubilization lead to the 
release of intracellular proteases that may digest the target protein. Therefore, 
inhibitors of proteases are included in the detergent lysis buffer, and the extract is to 
be kept on ice to prevent protein degradation. 
Equipment and solutions: 
Vortexer  
1 % FBS in PBS 
RIPA buffer 
 
 
RIPA buffer: 
1.25 ml Tris Hcl pH 8.0 (1 M) 
750 μl NaCl (5 M) 
50 μl Triton  
250 μl NaDeoxycholate (1 %) 
250 μl SDS (10 %) 
50 μl PMSF (0.1 M) 
25 μl Leupeptin (10 µg/ml) 
 
2.5 ml NaF (0.5 M) 
250 μl β-glycerophosphate (1 M) 
250 μl Na3VO4 
Distilled water to 20 ml 
Stored at -20˚C without aprotinin 
5 μl Aprotinin added pr ml RIPA  
The buffer is kept on ice when in use. 
 
Procedure: 
Cells are collected by centrifugation and washed with 500 µl PBS containing 1 % 
FBS. The cells are resuspended in the appropriate amount of Radio Immuno 
Precipitation Assay (RIPA) buffer (depending on the number of cells and size of the 
pellet), and incubated on ice for 20 min, while vortexed every 5 min. The cell 
membranes are collected by centrifugation at 13 800 x g for 20 min at 4˚C. The 
supernatant is transferred to a new tube, flash frozen in liquid N and stored at -70˚C. 
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3.6.2 Determination of protein concentration 
The Bio-Rad assay is used to quantify the concentration of proteins in the cell lysate. 
Binding of the protein to Coomassie brilliant blue G250 results in a shift in the 
absorption maximum of the dye from 465 to 595 nm, and this can be monitored by 
using a spectrophotometer. The absorbance of the sample is compared to a standard 
curve where the known protein concentration is set by gamma globulin (γ-globulin). 
Equipment and solutions: 
Eppendorf tubes  
Bio-Rad protein dye: dH2O (1:1) 
1 mg γ-globulin in 1ml dH2O 
 
Disposable cuvettes (1.5 ml) 
Spectrophotometer, Ultrospec 3000 
 
Procedure: 
Preparation of standards: 
RIPA buffer (2.5 µl) is added to standards of γ-globulin (2-20 µl) in a total volume of 
600 µl water. Two parallels of each standard are made. 
Preparation of samples: 
The samples are prepared in parallels by adding 2.5 µl of lysate to a total volume of 
600 µl water. 
400 µl of Bio-Rad protein dye is added to all the standards and samples, before they 
are transferred to disposable cuvettes. The absorbance at 595 nm is measured in a 
spectrophotometer according to the manufacturer, within 30 min. The protein 
concentrations in the lysate are then estimated from an obtained standard curve. 
3.6.3 Preparing a polyacrylamide gel 
Acrylamide is the basic element of the gel, and when ammonium persulfate (APS) is 
added, the free radicals generated initiate a chain reaction that results in the formation 
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of long chains of acrylamide from the initial monomers. As N,N-
methylenebisacrylamide (Bis) cross-bind the chains, the physical properties of the gel 
and its pore size are controlled by the proportion of polyacrylamide in the gel and its 
degree of cross linking. 
Equipment and solutions: 
SDS polyacrylamide gel (10 %) 
 
Bio-Rad Mini Protean П gel apparatus 
 
SDS polyacrylamide gel (10 %): 
Separating gel: 
3.3 ml acrylamide 
4 ml dH2O 
2.5 ml Tris-Hcl pH 8.8 (1.5 M) 
100 µl SDS (10%) 
50 µl APS 
5 µl TEMED 
 
Stacking gel: 
1.3 ml acrylamide 
6.1 ml dH2O 
2.5 ml Tris-Hcl pH 6.8 (0.5 M) 
100 µl SDS (10%) 
50 µl APS 
10 µl TEMED 
 
Procedure: 
Polyacrylamide gels were prepared according to the manual from Bio-Rad. For 
identification of p53, 10 % separating gels are used. 
3.6.4 Separation of proteins by SDS-PAGE 
SDS-PAGE (polyacrylamide gel electrophoresis) is a technique used to separate 
proteins on the basis of their size, as they migrate differently through a 
polyacrylamide gel in an electric field. Before loading the proteins onto a gel, 30 µg 
of protein from each lysate is transferred to eppendorf tubes. To denaturise the 
proteins they are boiled with the strong anionic detergent SDS in combination with 
the reducing agent β-mercaptoethanol. The denaturised polypeptides bind SDS and 
become negatively charged. The proteins then can be separated according to size. 
3. Materials and methods 
Equipment and solutions: 
Electrophoresis buffer  
Molecular weight standard 
3 x SDS sample buffer 
Heat block 
Syringe 
 
10 X Electrophoresis buffer: 
4 g Tris (Base) 
7 g Glycine 
50 g SDS  
Distilled water to 5 litre  
Diluted 1:10 when used 
 
3X SDS sample buffer: 
583 µl Tris-HCl pH 6.8 (1.5 M) 
2.57 ml SDS (10%) 
904 µl Glycerol (80%) 
 
125 µl β-mercaptoethanol 
818 µl dH2O 
5-10 µg Bromphenol Blue 
Procedure:  
The samples were prepared by dissolving equal amounts of proteins (20-40 µl cell 
lysate) in 3 x SDS sample buffer to a final concentration of 1 x SDS, boiled for 5 min 
and applied to the gel with a syringe. A molecular weight standard is applied to the 
gel to visualize the migration of proteins of various sizes. The gel is run at 200 V, 
constant voltage, and the separation time depends on the size of the protein. For p53 
analysis (53 kDa) the gel was run for approximately 45 min. 
 
Figure 14: SDS Polyacrylamide gel electrophoresis. See text for details. 
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3.6.5 Transfer of proteins from gel to nitrocellulose membranes 
The western blot analyses were carried out by direct electrophoretic transfer of 
proteins from the gel to a nitrocellulose membrane. Nitrocellulose bind proteins 
strongly and non-specifically, and the specific proteins can be visualized using highly 
selective antibodies. In our experiments we used a semi-dry transfer apparatus with 
plate electrodes in a horizontal configuration. 
 
Equipment and solutions: 
Hybond ECL Nitrocellulose membrane 
Whatman 3 MM paper 
 
Trans-Blot ® SD Semi-Dry Transfer cell 
Transfer buffer 
 
Transfer buffer: 
5.82 g Tris Hcl 
2.93 g Glycine 
3.75 ml SDS (10 %) 
200 ml methanol 
Distilled water to 1 litre 
 
Procedure: 
Following electrophoresis, the stacking gel is removed, and the gel is equilibrated in 
transfer buffer. Six pieces of Whatman paper and one piece of nitrocellulose filter is 
cut at the exact size of the SDS-gel and soaked in transfer buffer. 3 pieces of 
Whatman paper is placed in the transfer cell, the membrane is put on top of the 
papers, and the gel is put on top of the nitrocellulose membrane. Finally, the last 3 
Whatman papers are placed on top of the gel. Hence, the gel and the membrane are 
placed between the buffer-soaked filter papers, which serve as the ion reservoir and 
replace the buffer tank. Air bubbles are removed by rolling a glass tube over the 
sandwich. The cathode is placed onto the stack, and the proteins are transferred from 
the gel to the membrane at 17 V for 25 min.  
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Figure 15: Semi-dry transfer of proteins from gel to nitrocellulose membrane. 
3.6.6 Staining of proteins immobilised on nitrocellulose filters 
As control of equal loading, the amount of total protein in each lane is visualized by 
incubating the membrane in Ponceau solution. The red dye binds to the proteins and 
visualizes the amount of protein added to each lane. 
Equipment and solutions: 
Ponceau red solution  
TBS-Tween  
dH2O 
 
Ponceau red solution: 
0.1% Ponceau S  
5% acidic acid  
dH2O 
 
Procedure: 
The nitrocellulose membrane is incubated in Ponceau solution for 2 min before 
washing with distilled water to visualize the amount of protein in each lane. Before 
further processing of the membrane, the colour is removed by incubating the 
membrane in TBS-Tween for 2 x 2 min. 
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Figure 16: Ponceau-staining of proteins. 
3.6.7 Blocking unspecific binding of antibodies to the 
nitrocellulose membrane 
The sensitivity of the Western Blot analysis depends on reducing the background of 
non-specific binding of antibodies, by blocking potential binding sites with irrelevant 
proteins. The best and least expensive blocking-solution is based on non-fat dried 
milk. 
Equipment and solutions: 
8 % Nestle Molico non-fat dried milk in TBS-Tween  
Platform shaker 
 
 
 
Procedure:  
The membrane is incubated in 8 % non-fat dried milk in TBS-Tween for 45 min at 
room temperature on a platform shaker, or in 4˚C over night with gentle agitation. 
Excess blocking solution is washed away with TBS-Tween. 
3.6.8 Hybridisation of the filter with antibodies 
The proteins on the nitrocellulose membrane are hybridised in two stages. First, the 
blot is incubated for 45 min in a solution of an unlabeled antibody specific to the 
target protein in the presence of the milk/TBS-Tween reagent. After washing the blot 
with TBS-Tween for 3 x 10 min, the blot is incubated with a solution of anti-
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immunoglobulin coupled to HRP. After further washing, the antigen-antibody 
complex is identified by chemiluminescence and autoradiography. 
 
Figure 17: Antibodies are used to detect target protein. 
Equipment and solutions: 
Primary antibody solution 
Secondary antibody solution  
TBS-Tween 
Rock-n-roller 
Platform shaker 
 
Procedure: 
The blot is incubated with the primary antibody solution for 1.5 h at room 
temperature, or at 4˚C over night on a rock-n-roller. After washing the blot for 1 x 10 
min and 2 x 5 min in TBS-Tween on a platform shaker, the blot is incubated with the 
secondary antibody solution for 45 min at room temperature. After washing the 
membrane for 1 x 10 min and 3 x 5 min in TBS-Tween, the protein is visualised by 
chemiluminescence and autoradiography. 
3.6.9 Visualisation of specific proteins by chemiluminescence and 
autoradiography 
The secondary antibodies are coupled to HRP. The “ECL PlusTM Western blotting 
detection” system from Amersham Pharmacia Biotech provides a method for 
detection of immobilized antigens conjugated to HRP-labelled antibodies. HRP 
catalyses the oxidation of Lumigen PS-3 acridan substrate, generating thousands of 
 50 
3. Materials and methods 
acridinium ester intermediates per minute. These intermediates interact with peroxide 
under slight alkaline conditions to produce a sustained, high intensity 
chemiluminescence with maximum emission at 430 nm. 
Equipment and solutions: 
ECL PlusTM Western blotting detection system
Kodak X-omat 1000 processor 
HyperfilmTM 
Film cassette 
plastic wrap 
 
ECL PlusTM Western blotting detection system: 
Reagent A (ECL plus substrate solution containing Tris buffer) 
Reagent B (Stock Arcidan solution in Dioxane and Ethanol) 
Reagent A and B are mixed (1:40), 1 ml reaction fluid is used for each membrane. 
 
Procedure: 
After draining excess TBS-Tween, the membrane is placed with the protein side 
upwards on a piece of plastic wrap. The blot is incubated in the mixture of A and B 
reagents for 5 min at room temperature before excess detection fluid is drained off. 
The membrane is wrapped in plastic wrap and is in the dark room placed in a film 
cassette with the protein side against a sheet of HyperfilmTM. The film is exposed to 
the membrane for 1 second up to 30 min depending on the strength of the signal. The 
exposed film is run through an automatic film developer, and the protein recognized 
by the primary antibody will appear as black lines on the film. 
 
Figure 18: The proteins appear on the film after chemiluminescence and 
autoradiography. 
 51  
4. Results 
 52 
4. Results 
4.1 Regulation of proliferation of lymphoid cells by RA 
Conventional cancer treatments like γ-irradiation and chemotherapy is based on DNA 
damage responses, and it is well established that many chemotherapeutic agents 
depend on ongoing DNA synthesis to be effective (34;35;37). We have previously 
shown that elevation of cAMP inhibits DNA regulation and thereby also inhibits 
DNA damage induced by γ-irradiation and chemotherapy (72;74). Since our lab 
previously also has shown that retinoic acid stimulates and inhibits DNA synthesis 
and proliferation of normal T- and B cells, respectively (65;74), we anticipated that 
retinoic acid might regulate DNA damage responses differently in B- and T cells. 
However, we first had to confirm that retinoic acid indeed regulated the DNA 
synthesis in these cells. 
4.1.1 RA reduces proliferation of SAC stimulated B cells in a dose-
dependent manner 
B lymphocytes in peripheral blood exist in a resting phase (G0), and they remain in 
this phase of the cell cycle also after isolation by the use of magnetic Dynabeads (73) 
In vivo, B cells can be activated by specific antigens, and together with growth factors 
the cells will enter S-phase, proliferate and finally mature into plasma cells (41). In 
vitro, this activation can be mimicked by stimulating the B cells with anti-
immunoglobulins or various lectins known to crosslink the surface immunoglobulins. 
Staphylococcus Aureus Cowan (SAC) is a crude bacterial cell suspension that 
activates B cells via lectins at the bacterial surface (41). We wished to see how RA 
affected the proliferation of B cells, and we used forskolin to compare the effect of 
RA. Proliferation was indirectly measured as DNA synthesis based on incorporation 
of [3H] thymidine into DNA in S-phase. 
4. Results 
 
Figure 19: Effect of RA and forskolin on proliferation of B cells 
Normal human B cells were isolated from buffycoats, as described in Materials and 
Methods. Cells (100 000/well) were stimulated with SAC (1:20000), RA and 
forskolin as indicated for 72 h. [3H] thymidine was added, and DNA synthesis was 
measured as described in Materials and Methods. The values represent the median of 
triplicates, and the vertical bars represent the range of the triplicates in the 
experiment. 
 
As can be seen in figure 19, RA reduced the proliferation of SAC-stimulated B cells 
in a concentration-dependent manner. As compared to the 50 % reduced DNA 
synthesis in the presence of 100 nM RA, forskolin reduced the proliferation of the 
cells by 90 %. 
4.1.2  RA does not inhibit DNA damage-induced apoptosis in 
normal B cells isolated by overnight detachment 
Based on the inhibiting effect of RA on DNA synthesis in B cells, we wished to 
examine if RA would reduce apoptosis induced by DNA damage. To induce DNA 
damage in B cells, we exposed the cells to γ-irradiation at 10 Gy. 
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Figure 20: Effect of RA on DNA damage-induced apoptosis in normal 
B cells isolated by overnight detachment 
Normal B cells were isolated from buffycoats by overnight detachment of the cells 
from the Dynabeads as described in Materials and Methods. Cells (1.5 x 106 
cells/ml) were stimulated with SAC (1:20000) for 22 h, and RA (100 nM) or 
forskolin (100 µM) was added 2 h before IR (10 Gy). 20 h after IR, apoptosis was 
analyzed by uptake of propidium iodine as described in Materials and Methods (n = 
2, mean ± range). 
 
As shown in figure 20, the viability of B cells isolated by detachment from 
Dynabeads over night was low. After culturing the cells for 20 h, 63 % of the cells 
were dead. γ-irradiation did not markedly increase the percentage of apoptotic cells, 
and RA or forskolin did not reduce this cell death. We could conclude that overnight 
detachment of the cells was not a suitable method for isolating B cells for analysing 
cell death. 
4.1.3 Effect of RA on DNA damage-induced apoptosis in normal B 
cells isolated by Detachabeads 
Since B cells isolated by allowing the cells to detach from the Dynabeads over night 
had low viability, we wished to isolate the cells by an alternative method based on 
DETACHaBEAD®CD19. This method rapidly detaches the beads from the cells. 
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Again we analyzed the viability of the cells before and after induction of DNA 
damage by γ-irradiation, and the effect of RA on this process was assessed. 
 
Figure 21: Effect of RA on DNA damage-induced apoptosis in normal B cells 
isolated by the detachabead method 
Normal B cells were isolated from buffycoats by the use of the detachabead 
method as described in Materials and Methods. Cells (1.5 x 106 cells/ml) were 
stimulated with SAC (1:20000) for 22 h. and RA was added 2 h before IR (10 
Gy). 20 h after IR, apoptosis was analyzed by uptake of propidium iodine as 
described in Materials and Methods (n= 4, mean ± SEM). 
 
As shown in figure 21, the Detachabead method improved the viability of the 
isolated B cells as compared with cells isolated by overnight detachment. Thus, the 
percentage of apoptotic cells after 20 h of culturing was reduced to 32 %. DNA 
damage induced by γ-irradiation increased the percentage of the apoptotic cells to 50 
%, and RA had a small, but reproducible inhibiting effect on the DNA damage-
induced apoptosis. However, since the effect was only marginal, we concluded that 
we did not wish to further study the effect of RA in this cell system. 
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4.1.4 RA has no effect on DNA damage-induced cell death in 
Epstein-Barr virus transformed B cells 
It has been shown that RA inhibits the proliferation of Epstein-Barr virus (EBV) 
transformed B cells (75). EBV transformation of B cells is a common method for 
making cell lines of normal B cells, and in our lab we have recently shown that 
forskolin inhibits DNA damage-induced apoptosis of EBV+ B cells (Kloster et al 
2008, journal in press). We used one of the cell lines established in our lab to 
measure the effects of RA on DNA damage-induced apoptosis. DNA damage was 
again induced by γ-irradiation. 
 
Figure 22: Effect of RA on DNA damage-induced apoptosis in EBV+ B cells 
RA was added to EBV+ B cells (0.7 x 106 cells/ml) 24 h prior to IR (10 Gy). 20 
h after IR, apoptosis was analyzed by uptake of propidium iodine as described in 
Materials and Methods (n = 3, mean ± SEM). 
 
As shown in figure 22, γ-irradiation of the cells enhanced the cell death from 27 % to 
66 %. RA had only a marginal effect on the DNA damage-induced cell death. From 
the results on normal B cells and EBV+ B cells we could conclude that RA did not 
have profound effect on DNA damage-induced apoptosis in B cells. 
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4.1.5 RA potentiates T cell proliferation 
We now wished to elucidate the effects of RA on DNA damage-induced cell death in 
T cells. Since previous results from our lab has shown that RA enhances proliferation 
of T cells (65), we anticipated that RA might enhance DNA damage-induced 
apoptosis. First, however we had to confirm prior results in our lab on the effect of 
RA on DNA synthesis in normal human T cells. Phytohemagglutinin (PHA) is a plant 
lectin, especially abundant in beans, and it is known to stimulate T cells to proliferate 
by crosslinking the T cell receptor (40). Normal T cells were isolated from peripheral 
blood, and the effect of RA was measured in PHA-stimulated cells. 
 
Figure 23: Effect of RA on T cells stimulated with PHA 
Normal human T cells were isolated from buffycoats, as described in Materials 
and Methods. Cells (100 000/well) were stimulated with PHA (5µg/ml) in the 
presence or absence of RA for 72 h. [3H] thymidine was added, and 
incorporation was measured as described in Materials and Methods. The values 
represent the median of triplicates (± range). 
 
As shown in figure 23, RA enhanced the DNA synthesis of PHA-stimulated T cells 
by 32 % as compared to untreated cells. The stimulatory effect of RA on proliferation 
of human T cells was therefore confirmed. 
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4.1.6 RA reduces DNA damage-induced apoptosis in PHA-
stimulated T cells 
Having confirmed that RA potentiates proliferation of PHA-treated T cells, we now 
elucidated the effect of RA on DNA damage-induced apoptosis. To induce DNA 
damage, the cells were γ-irradiated. Since we had previously shown that forskolin 
inhibits DNA damage-induced apoptosis (Kloster et al 2008, journal in press), we 
included forskolin as a control. 
 
Figure 24: Effect of RA and forskolin on DNA damage-induced 
apoptosis in T cells stimulated with PHA 
Normal human T cells were isolated from buffycoats, as described in Materials 
and Methods. Cells (2.0 x 106 cells/ml) were stimulated with PHA (5µg/ml) for 
22 h, and RA or forskolin was added 2 h before IR (10 Gy). 20 h after IR, 
apoptosis was analyzed by uptake of propidium iodine as described in Materials 
and Methods (n =5, mean ± SEM). 
 
As shown in figure 24, the viability of the isolated T cells was high, and γ-irradiation 
enhanced the apoptosis from 5 to 38 %. There was a small, but reproducible 
inhibitory effect of RA on DNA damage-induced apoptosis. Since we had expected 
that RA would enhance rather than inhibit DNA damage-induced apoptosis, the 
findings were unexpected. We therefore decided to proceed the results. 
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4.1.7 The effect of RA on DNA damage-induce apoptosis is time-
dependent  
Previous work in our lab had proven that RA had to be added to the T cells early 
during stimulation in order to enhance the proliferation (65). We therefore 
investigated if this was the case for RA on DNA damage-induced apoptosis in T 
cells. Thus, we added RA to T cells 2 h or 24 h prior to γ-irradiation. 
 
Figure 25: The kinetics of the effect of RA on DNA damage-induced 
apoptosis in PHA stimulated T cells 
Normal human T cells were isolated from buffycoats, as described in Materials 
and Methods. Cells (2.0 x 106 cells/ml) were stimulated with PHA (5µg/ml) for 22 
h, and RA or forskolin was added 2 h or 24 h prior to IR (10 Gy). 20 h after IR 
apoptosis was analyzed by uptake of propidium iodine as described in Materials 
and Methods (n = 2, ± range). 
 
As shown in figure 25, there was a tendency that the effect of RA on DNA damage-
induced apoptosis was stronger when RA was added to the cells 24 h before γ-
irradiation as compared to 2 h prior to γ-irradiation. Based on this result, RA was 
added 24 h before γ-irradiation in the remaining experiments. 
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4.1.8 The phorbol ester TPA potentiates T cell proliferation 
Previous results in our lab had indicated that RA had a stronger stimulatory effect on 
T cells stimulated with the phorbol ester tumor 12-O-tetradecanoylphorbol 13-acetate 
(TPA), than cells stimulated with PHA (Å. Ertesvåg, personal communication). TPA 
induces proliferation of many cell types by mimicking diacylglycerol to stimulate 
protein kinase C (PKC) (76). We wished to examine if RA would affect DNA 
damage-induced apoptosis differently in cells stimulated with TPA than cells 
stimulated by PHA. Again we had to confirm prior results in our lab on effects of RA 
on DNA synthesis of the cells before DNA damage could be analyzed. Thus, normal 
T cells were isolated from peripheral blood, and the effect of RA on proliferation was 
measured in TPA-stimulated cells. 
 
Figure 26: Effect of RA on proliferation of T cells stimulated with TPA 
T cells were isolated from buffycoats, as described in Materials and Methods. 
Cells (100 000/well) were stimulated with or without TPA, in the presence or 
absence of different concentrations of RA for 24 h. [3H] thymidine was added, 
and DNA synthesis was measured as described in Materials and Methods. The 
values represent the median of triplicates (± range). 
As shown in figure 26, RA enhanced the DNA synthesis of TPA-stimulated T cells. 
The stimulatory effect of RA on proliferation of TPA-stimulated T cells was therefore 
confirmed. 
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4.1.9 RA inhibit DNA damage-induced apoptosis in TPA stimulated 
T cells 
Having confirmed that RA potentiates proliferation of TPA-treated T cells, we now 
wished to investigate how RA affected DNA damage-induced apoptosis. 
 
Figure 27: Effect of RA on DNA damage-induced apoptosis in T cells 
stimulated with TPA  
Normal human T cells were isolated from buffycoats, as described in 
Materials and Methods. Cells (2.0 x 106 cells/ml) were stimulated with TPA 
and RA for 24 h prior to IR (10 Gy). 20 h after IR, apoptosis was analyzed by 
uptake of propidium iodine as described in Materials and Methods (n = 9, 
mean ± SEM). 
 
As shown in figure 27, TPA alone induced apoptosis in 45 % of the cells. Irradiation 
enhanced this apoptosis to 60 %, and RA reduced the cell death. However, the high 
percentage of cell death in TPA-treated cells was a problem, and we therefore wished 
to test lower concentrations of TPA. 
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4.1.10 Dose-respond of TPA 
We now wished to examine how RA affects cell death induced in γ-irradiated T cells 
stimulated with different concentrations of TPA. 
 
Figure 28: Effect of RA on DNA damage-induced cell death in T cells 
stimulated with different concentrations of TPA  
Normal human T cells were isolated from buffycoats, as described in Materials and 
Methods. Cells (2.0x 106 cells/ml) were stimulated with or without different 
concentrations of TPA in the presence or absence of RA for 24 h prior to IR (10 
Gy). 20 h after IR, apoptosis was analyzed by uptake of propidium iodine as 
described in Materials and Methods (n = 4, mean ± SEM). The black bars represent 
cells stimulated with 10-9 M TPA. 
 
As shown in figure 28, only 15 % of the cells were dead when cultured in 10-9 M 
TPA alone, and the strongest effect of RA on DNA damage-induced apoptosis was 
obtained at this concentration of TPA. Thus, the cell death was reduced by 
approximately 50 % when RA was added to γ-irradiated cells stimulated with 10-9 M 
TPA as compared with only 12 % and 22 % reduction in γ-irradiated cells stimulated 
with TPA 5x10-9 M or 10-8 M respectively. In the remaining experiments, the cells 
were therefore stimulated with 10-9 M TPA. 
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4.1.11 Dose-respond and kinetics of RA 
The concentration of all-trans RA in peripheral blood is ~ 10 nM (77). Previous work 
in our lab had shown that RA potentiate DNA synthesis of TPA-stimulated T cells in 
a concentration- and time dependent manner (65). First we therefore wished to 
elucidate how different concentrations of RA affected DNA damage-induced 
apoptosis in T cells stimulated with TPA. 
 
Figure 29: The effect of concentration of RA on DNA damage-induced 
cell death in T cells stimulated with TPA 
Normal human T cells were isolated from buffycoats, as described in Materials 
and Methods. Cells (2.0 x 106 cells/ml) were stimulated with or without TPA in 
the presence or absence of different concentrations of RA 24 h prior to IR (10 
Gy). 20 h after IR, apoptosis was analyzed by uptake of propidium iodine as 
described in Materials and Methods (n = 3, mean ± SEM). 
 
As shown in figure 29, RA reduced DNA damage-induced cell death in a 
concentration dependent manner, the effect being optimal at 100 nM. This 
concentration was therefore used in the remaining trials. 
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4.1.12 The effect of RA on DNA damage-induced apoptosis is time-
dependent 
To elucidate if the time of addition of RA was critical for its inhibitory effect on 
DNA damage-induced apoptosis, RA was added to the cells 1-24 h prior to γ-
irradiation. 
 
Figure 30: The effect of time of RA addition on DNA damage-induced cell 
death in T cells stimulated with TPA 
Normal human T cells were isolated from buffycoats, as described in Materials 
and Methods. Cells (2.0 x 106 cells/ml) were stimulated with or without TPA in 
the presence or absence of RA added 1-24 h prior to IR (10 Gy). 20 h after IR, 
apoptosis was analyzed by uptake of propidium iodine as described in Materials 
and Methods. 
 
As shown in figure 30, RA inhibited cell death in a time-dependent manner. Best 
effects were obtained when RA was added 24 h prior to γ-irradiation. 
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4.1.13 The DNA damage-induced cell death in normal T cells is 
apoptotic and not necrotic 
In viable cells, the cell membrane is intact and excludes charged dyes like propidium 
iodine (PI). In contrast, the membrane in dead or dying cells are leaky, and this result 
in uptake of PI and staining of DNA. Dead cells are therefore stained by PI, whereas 
viable cells have no or minimal uptake of the dye (78). However, PI-staining of cells 
does not discriminate between cells dead by necrosis or by apoptosis. In order to 
verify that DNA damage induced apoptosis and not necrosis, we also analyzed the 
cells by flow cytometric scatter analysis. Side scatter indicates the granularity of the 
cells, whereas forward scatter measures the cell size. Apoptotic cells are smaller and 
more granular than viable cells, whereas necrotic cells are larger than viable cells 
(78). We therefore analyzed the effect of RA on irradiation-induced cell death by 
scatter analysis. 
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Figure 31: DNA damage-induced cell death in T cells measured by scatter analysis 
and incorporation of PI 
Normal human T cells were isolated from buffycoats, as described in Materials and 
Methods. Cells (2.0 x 106 cells/ml) were stimulated with or without TPA, in the presence 
or absence of RA 24 h prior to IR (10 Gy). 20 h after IR, apoptosis was analyzed by 
scatter analysis (panel A and B), or by uptake of propidium iodine (panel C and D) as 
described in Materials and Methods (n = 15, mean ± SEM). 
As shown in figure 31 A, there was a significant reduction in DNA damage-induced 
cell death measured by a shift in scatter when RA (100 nM) was added 24 h prior to 
γ-irradiation (n = 15, ± SEM, Paired samples T-test: * p < 0.001, mean (13.55), 95 % 
CI [7.87-19.22], SD (10.24)). The same results were obtained when cell death was 
analyzed by uptake of PI (figure 31 C). Thus, when PI-incorporation was measured, 
there was a significant reduction in DNA damage-induced cell death when RA was 
added 24 h prior to γ-irradiation (n = 15, ± SEM, Paired samples T-Test: * p = 0.001, 
mean (10.56), 95 % CI [5.44, 16.88], SD (8.86)). Figure B and D show the 
flowcytometry histograms of one of the experiments presented in figure A and C. 
Thus, figure B represent scatter analysis of the cells, whereas figure D represent 
uptake of PI. We could conclude that γ-irradiation of TPA-treated cells induced 
apoptosis. The PI-uptake and scatter analysis gave similar results, and RA clearly 
reduced the DNA damage-induced apoptosis as measured by both methods. 
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4.1.14 RA reduces DNA damage-induced cell death in T cells 
treated with doxorubicin 
Having demonstrated that RA reduced irradiation-induced apoptosis in stimulated T 
cells, we wished to investigate the effects of RA on other DNA-damaging agents. 
Doxorubicin (DOX) is a chemotherapeutic agent used in treatment of a broad 
spectrum of human cancers including lymphomas (35;79). It induces apoptosis by 
inhibiting topoisomerase ІІ, which unwinds DNA for transcription. Doxorubicin 
stabilizes the topoisomerase ІІ complex after it has broken the DNA chain for 
replication (36). For comparison of cell death we used γ-irradiated cells. 
 
Figure 32: Effect of RA on cell death induced by doxorubicin or IR 
Normal human T cells were isolated from buffycoats, as described in Materials and 
Methods. Cells (2.0 x 106 cells/ml) were stimulated with TPA in presence or the absence of 
RA for 24 h prior to IR (10 Gy) or treatment with different concentrations of doxorubicin. 
20 h after IR or treatment with doxorubicin, apoptosis was analyzed by uptake of 
propidium iodine as described in Materials and Methods. 
As shown in figure 32, RA reduced DNA damage-induced apoptosis also when DNA 
damage was enforced by doxorubicin. The effect of RA was strongest (70 % 
reduction) at 750 nM doxorubicin, and at this concentration of doxorubicin, the 
inhibitory effect of RA was even stronger than its effect on γ-irradiated cells. 
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4.2 Determination of p53 expression downstream of DNA 
damage in T cells 
Expression of active p53 is induced in response to DNA damage (27). Recent studies 
in our lab have shown that cAMP inhibits apoptosis induced by DNA damaging 
apoptosis like γ-irradiation, and that this inhibition involves down-regulation of p53 
(E. Hallan, unpublished data). 
4.2.1 RA reduces p53 expression in γ-irradiated T cells  
In order to assess the levels of p53 upon induction of DNA-damage, we performed 
Western Blot analysis of the cells after γ-irradiation. We used the same conditions as 
we had previously found to be optimal for assessing the effect of RA on DNA 
damage-induced apoptosis, i.e. stimulation of the cells with 10-9 M TPA and 24 h 
pretreatment with RA prior to γ-irradiation. 
 
Figure 33 panel 1: Effect of RA on irradiated-induced p53 in T cells stimulated 
with TPA 
T cells were incubated with or without TPA, in the presence or absence of RA for 24 h 
prior to exposure to IR (10 Gy). The cells were harvested 20 h after IR, and equal 
amounts of protein (30 µg) were separated on a 10 % polyacrylamide gel before 
performing Western blot analysis using antibodies against p53. For visualization of 
loading, the blot was rehybridized with antibodies against actin. Three representative 
blots are shown. 
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TPA alone did not induce p53, but as expected γ-irradiation induced a pronounced 
elevated expression of the p53 protein in the TPA-treated cells. RA treatment reduced 
the p53-expression as demonstrated in all three Western blots depicted in figure 33, 
panel 1. 
In order to verify the inhibitory effects of RA on irradiation-induced p53 expression, 
the three Western blots in figure 33, panel 1 were scanned using Scion Image 
software. 
 
Figure 33, panel 2: Relative expression of p53 
Western blots of p53 and actin expression were scanned by Scion Image software. The 
p53 levels were normalized against actin, and the relative expression of p53 was 
measured (n=3, mean ± SEM). 
 
As shown in figure 33, panel 2, it was clear that γ-irradiation induced p53 expression 
in TPA-treated T cells. RA reduced the expression of p53 by 65 %. 
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Deregulation of the cell cycle may lead to tumor formation. When genes encoding 
components of the programmed cell death pathway mutate, cells with damaged DNA 
may continue to proliferate. This will in turn result in new mutations and eventually 
tumor formation. Conventional cancer treatment such as γ-irradiation and use of 
chemotherapeutic agents act via DNA damage-induced apoptosis. The treatment is an 
effective way of reducing the amount of tumor cells, but at the same time the side 
effects of the treatment can be that our immune cells respond to the DNA damage and 
may commit to apoptosis. Vitamin A strengthen the immune system by preventing 
and fighting infection (46;49), but the mechanisms involved are not yet fully 
understood. In our lab we have previously shown that RA inhibits the proliferation of 
naïve B cells, but stimulates the proliferation of memory B cells as well as T cells 
(56;58;65;80). 
Upon DNA damage, the transcription factor p53 is stabilized and activated to induce 
target genes involved in growth arrest, DNA repair and apoptosis. p53 is a tumour 
suppressor and an important downstream mediator of DNA damage responses (27). 
The aims of this paper were to reveal the effects of RA on DNA damage-induced 
apoptosis in human B- and T cells. In particular we wished to elucidate the effects of 
RA on regulation of p53 expression upon induction of DNA damage in lymphoid 
cells. But firstly, we discuss some methods used in this thesis. 
5.1 Methodological considerations 
5.1.1 Cell systems 
Normal lymphocytes have limited lifespan and the isolation from peripheral blood is 
time-consuming, expensive, and gives a low yield of cells. As cell lines derived from 
malignant lymphocytes are easy to culture, and it is easy to obtain a large number of 
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cells, they have become valuable tools in the study of lymphoid cell biology. 
However, in order to understand relevant mechanisms in a physiological context, it is 
better to use normal cells compared to cell lines. This is because cell lines usually 
possess numerous genetic alterations as they often are derived from cancer cells. 
Another advantage of using normal lymphocytes is that the majority of the cells are 
naturally synchronized in the G0 phase of the cell cycle, thereby avoiding procedures 
to synchronize the cells. The data obtained from normal cells are therefore often 
easier to interpret than results from cell lines. However, when it comes to doing 
research on normal human cells, it is of importance to consider human variety. It is 
generally accepted that the cellular responses of lymphoid cells can vary substantially 
between different blood donors (65). 
In this thesis we have primarily studied normal human B- and T cells, but a few 
experiments were performed on EBV-transformed B cells. Epstein Barr virus has a 
unique ability to transform resting B cells into permanent, latently infected 
lymphoblastoid cell lines. We isolated B lymphoid cells from peripheral blood of 
human blood donors (buffycoats) using antibody-coated Dynadeads (anti-CD19 
antibodies). The yield of B cells is usually 10-40 x 106 B cells per buffycoat. Based 
on the cell death analysis done by flow cytometry, a high amount of cells died when 
cells were left over night to detach from the beads. Therefore, we removed the beads 
by adding Detachabeads to the cells, which gave a higher percentage of viable cells. 
T cells can be negatively or positively isolated; the first method we used was based 
on removing contaminating cells, whereas the method we finally chose (and present 
in the thesis) is based on positive isolation of the T cells. We isolated T cells from 
buffycoats by positive selection, using CD4+ beads. This method gave high viability 
of the cells, and provided a pure CD4+ T cell population. We typically obtained 50-
100 x 106 CD4+ T cells from one buffycoat, and the purity was approximately 98 %. 
The advantage of using peripheral blood lymphocytes compared to cells from other 
lymphoid tissue is both that it is easy to obtain a large number of lymphocytes from 
peripheral blood, and that peripheral blood contain fewer in vivo activated cells than 
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cells isolated from for instance tonsils. This eliminates the problems of different 
responses in activated and resting cells. 
5.1.2 Activation of lymphoid cells 
Mounting an appropriate immune response depends on the careful regulation of 
lymphocyte activation. Stimulation of lymphocytes by antigen or mitogen results in 
macromolecular synthesis (DNA, RNA and protein) and production of lymphokines 
followed by proliferation and differentiation of the progeny into various effector and 
memory cells. To study immune responses in vitro, we activated the lymphoid cells. 
To stimulate B cells we used Staphylococcus Aureus Cowan (SAC). SAC mimics 
antigen stimulation by cross linking surface receptors of B cells and driving them into 
S-phase. With this stimulus approximately 30 % of the cells enter S-phase (41). T 
cells can be activated by components that interact with the T cell receptor, or by the 
use of pharmacological agents which circumvent receptor activation. Mitogenic 
lectins such as concanavalin A (Con A) or PHA interact with cell surface T cell 
receptor (81). TPA, a chemical tumor-promoting agent, is an effective mitogen for 
peripheral blood lymphocytes. It activates PKC by mimicking diacylglycerol (DAG) 
(76). Another chemical agent for activation of T cells is the calcium ionophore 
ionomycin which enhances the calcium levels in the cells (82). In this thesis, we used 
TPA or PHA to stimulate T cells. The advantage of using polyclonal activators like 
SAC, PHA, Con A or TPA to stimulate lymphocytes is that large percentages of the 
cells are driven into the cell cycle. This makes it easier to measure downstream 
effects. 
5.1.3 Determination of cell proliferation 
Incorporation of radioactive thymidine into DNA is a commonly used method for 
determining cell proliferation. The amount of radioactivity incorporated in the cells, 
reflects DNA synthesis in S-phase of the cell cycle. There is however some 
limitations related to this method. It has been reported a lack of correlation between 
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thymidine incorporation and cell proliferation in lectin-stimulated lymphocytes (83). 
Furthermore, the results give no accurate information about the amount of cells that 
are present in S-phase. Nevertheless, the advantage of determining DNA synthesis 
rather than for example direct cell counting is that the procedure is easy to perform 
and many samples can be analyzed simultaneously. 
5.1.4 Determination of cell death 
A common method for measuring cell death is based on propidium iodine (PI) uptake 
by dead and dying cells, as viable cells exclude charged dyes like PI because of the 
intact membrane. The PI uptake is analyzed by flow cytometry (78). The advantage 
of this method is that it is simple and of low cost, but it does not distinguish between 
necrotic and apoptotic cells. An alternative method for discriminating between viable 
and dead cells is scatter analysis by flow cytometry (84). In contrast to necrotic cells, 
which typically swell (due to plasma membrane dysfunction), apoptotic cells 
typically shrink and become more granular. However, caution should be made when 
studying apoptosis by this method, because decreased light scattering properties are 
not specific to apoptosis since both mechanically broken cells, isolated cell nuclei and 
necrotic cells can have low light scatter properties. Cell death can also be measured 
by the TUNEL method which detects DNA strand breaks by TdT-mediated dUTP 
nick end-labeling (TUNEL) of apoptotic cells, or by measuring changes in the 
membrane potential of dying cells (66). Since previous work in our lab (66) has 
proved that these two latter methods to assess cell death give the same results as 
scatter light analysis, we analyzed cell death by measuring changes in scatter light in 
addition to uptake of PI. 
5.1.5 Retinoic acid 
At the end of an immune response, most activated T cells die through activated T cell 
autonomous death (ACAD), a process in which activated T cells commit to apoptosis 
because survival signals fade some time after T cell activation (85). Previous work in 
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our lab has proven that retinoic acid (RA) prevents this process (66), and that it at the 
same time enhances the T cell proliferation (65). In vivo, retinol is transported in 
plasma bound to retinol-binding protein (RBP), and it is taken up by target cells via 
RBP-receptors (77). The plasma concentration of retinol-RBP is strictly regulated, 
and it is normally between 1 and 3 μM. Newly absorbed retinol is also present as 
retinyl esters in chylomicrons and their remnants. Retinyl esters in these particles can 
be taken up by the cells via LDL-receptor-related proteins (77). The intake of 
pharmacological concentration of retinol will result in plasma concentrations of 
retinyl esters in chylomicrons remnants of 10-30 μM (86). Only small amounts (~ 5-
10 nM) of retinoic acid are normally found in plasma. During retinoic acid therapy, 
however, the concentration may increase considerably. For example, the intake of 50 
mg RA will result in peak plasma concentrations of about 0.5 μM (86). In most in 
vitro studies retinoids are administered to the cells solubilised in ethanol, and it is 
reported that in such studies concentrations of RA above 1 µM generally are 
considered to be toxic (65). It has been shown that RA can be directly taken up by 
cells both in vitro and in vivo (87;88), and in previous paper our group demonstrated 
that similar effects were obtained on B cell growth by RA solubilised in ethanol as 
with retinol bound to RBP and by retinol esters (55). To study the effect of retinoids 
on B- and T cell proliferation as well as on DNA damage-induced apoptosis, retinoic 
acid, the major active retinoid metabolite, was used in this thesis. We could generally 
detect effects of RA at concentrations as low as 10 nM, but in most experiments we 
used the optimal concentration of 100 nM. 
5.1.6 Protein expression of p53 
In the present thesis we studied RA-mediated regulation of p53 expression in γ-
irradiated T cells by Western Blot analysis. To ensure that an equivalent amount of 
proteins was present in each of the samples, we used actin as a control. Actin is a 
cytoplasmic protein present at high constitutive levels, and this protein is commonly 
used as a loading control. We also measured the relative expression of p53 by the use 
5. Discussion 
 76 
of the software Scion Image, where we normalized the p53 labeling with the actin 
labeling. 
5.2 Discussion of the results 
5.2.1 The effect of RA on DNA damage-induced apoptosis 
The important role of retinoids in the immune system has been underlined by 
numerous studies (49). A part of the increased resistance to infection has been 
ascribed to improved epithelial integrity, but a direct effect on the immune system is 
well established (48;89). The key regulatory event in the G1/S-phase transition of the 
cell cycle is the phosphorylation of pRB (90), and previous work in our lab has 
proven that RA markedly enhanced TPA-mediated pRB phosphorylation in T cells 
(65), whereas SAC-mediated pRB-phosphorylation of B cells was inhibited (57;65). 
Consistent with these previous findings we found that the proliferation of B cells was 
inhibited by physiological levels of retinoids, whereas the T cells were stimulated by 
RA. This cannot be ascribed to the fact that different mitogens were used to stimulate 
T- and B cells, as previous work in our lab has shown that RA also inhibits the 
proliferation of TPA-stimulated B cells (Å. Ertesvåg, personal communication). 
Many DNA-damaging agents rely on DNA-replication to be effective (72). Previous 
work in our lab has shown that inhibition of lymphocyte-proliferation by elevated 
levels of cAMP also prevented DNA damage-induced apoptosis (72). Since RA 
enhanced and inhibited the proliferation of T- and B cells respectively, we anticipated 
that DNA damage-induced apoptosis would be enhanced and reduced, respectively in 
the two cell types. However, in contrast to what we expected, DNA damage-induced 
apoptosis was inhibited in both normal B cells, EBV-transformed B cells and in 
normal T cells. Interestingly, the inhibitory effect was particularly strong in T cells.  
When doing research on normal human lymphocytes, it is of importance to consider 
human variety. It is generally accepted that the cellular responses of T cells can vary 
substantially between different blood donors (66). Of the 5 first donors examined for 
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T cell apoptosis, we noticed that T cells from one of the donors responded much 
stronger to RA than the four others. We therefore extended the results by including a 
total of 15 donors. In the initial studies the T cells were stimulated with PHA, but 
since previous results in our lab had shown that TPA is a stronger stimulus than PHA 
(Å. Ertesvåg, personal communication), we used TPA to stimulate the T cells isolated 
from the 15 donors. It has previously been shown that concentrations above 3 x 10-9 
M TPA inhibits proliferation of certain cell types (91). We therefore assessed 
different concentrations of TPA, and found that 10-9 M TPA was the strongest 
inducer of T cell proliferation. From a total of 15 donors, we found that RA 
significantly (p < 0.001) reduced the apoptosis of γ-irradiated T cells stimulated with 
10-9 M TPA. TPA mimics diacylglycerol in activation of PKC (76), and it has been 
shown that retinoids in certain cell types can regulate PKC activity (92). However, 
previous work in our lab has shown that there was no potentiation of PKC-activity in 
RA-treated T cells (65). 
It has, however, been shown that RA induces IL-2 production in TPA-stimulated T 
cells (65;66) and it is possible that this IL-2 production might prevent apoptosis 
induced by γ-irradiation of RA-treated cells. Consistent with a role of IL-2 in this 
process, we observed that RA had a stronger inhibitory effect on DNA damage-
induced apoptosis when it was added to TPA-treated T cells early during stimulation 
(24 h before γ-irradiation) compared to 2 h before γ-irradiation. 
In addition to reducing apoptosis in lymphoid cells after exposure to γ-irradiation, we 
showed that RA also reduces DNA damage-induced apoptosis in T cells exposed to 
cytotoxic chemical agents. Doxorubicin is used in treatment of a broad spectrum of 
human cancers. The chemical has been shown to stimulate both intrinsic 
(mitochondria-mediated) and extrinsic (Fas ligand-mediated) pathways of apoptosis 
in cellular and in vivo models (34). In tumor cells, doxorubicin causes early activation 
of p53 followed by caspase-3 activation and DNA fragmentation, resulting in 
apoptosis (34). A side effect is that doxorubicin induces apoptosis in normal cell 
types, for example endothelial cells, cardiomyocytes and peripheral blood 
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lymphocytes (34;79). However, doxorubicin induces apoptosis in normal and tumor 
cells via distinctly different mechanisms. In normal cells, doxorubicin induces 
apoptosis by a H2O2-mediated mechanism and is largely independent of p53 
activation (34). To be able to compare the effects of RA on doxorubicin-treated T 
cells and irradiated T cells, we aimed for the same degree of apoptosis after both 
treatments. We found that 750 nM doxorubicin gave approximately the same 
percentage of apoptotic cells as cells exposed to γ-irradiation at 10 Gy. When using 
this concentration of doxorubicin, the inhibitory effect of RA was even stronger than 
its effect on γ-irradiated cells. Thus, doxorubicin-induced apoptosis was reduced by 
70 %, whereas RA inhibited apoptosis induced by γ-irradiation by approximately 35 
%. 
5.2.2 The effects of RA on regulation of p53 expression upon 
induction of DNA damage in lymphoid cells 
In order to understand how RA inhibits apoptosis induced by DNA-damaging agents 
like γ-irradiation and doxorubicin in normal T cells, we investigated the events 
downstream of DNA damage. The DNA damage checkpoint is characterized by the 
ATM/ATR-CHK1/CHK2 pathway (16;26). The activation of CHK1/CHK2 by 
ATM/ATR leads to phosphorylation, stabilization, and activation of p53, and this will 
in turn lead to p53-mediated induction of genes involved in growth arrest, DNA 
repair and apoptosis (27). Also transcription-independent effects of p53 are induced 
(28). As p53 is such a critical mediator of the DNA-damage checkpoint, we studied 
the effect of RA on p53-expression. We showed that γ-irradiation of the TPA-
stimulated T cells induced p53 expression, and that RA inhibited this induction by 
65%. The present study is the first to assess the effect of RA on DNA damage-
induced apoptosis in any cell type. In our lab, we have previously shown that RA 
prevents spontaneous apoptosis of normal B cells (59), and in melanoma cells RA has 
been shown to increase apoptosis (93). In the melanoma cells the induced apoptosis 
was accompanied by enhanced expression of p53 (93). 
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5.3 Future perspective 
How RA inhibits the level of p53 in γ-irradiated T cells will be further studied by our 
lab. The effects on upstream mediators like activation of ATM/ATR or CHK1/2 will 
be studied by phospho-specific antibodies to active forms of these proteins. We will 
also examine at which level p53-expression is inhibited by RA. Generally, the 
expression of p53 is mainly regulated at the level of stability, with HDM-2-mediated 
degradation of p53 in proteasomes as the main mechanisms (31). We can not, 
however, exclude the possibility that RA inhibits the transcription of p53. Several 
hundred genes are directly or indirectly regulated by RA (94), but p53 is not one of 
the genes directly regulated. Thus, if RA inhibits the expression of p53 at the 
transcriptional level, the effect must be indirect. The C terminal region of p53 forms a 
region that has key regulatory properties. Modification of this region by acetylation, 
phosphorylation, O-glycosylation, and RNA binding have been reported, but the 
physiological significance of these post-translational modifications remains uncertain 
(95). It has been shown that RA can alter the glycosylation pattern of various 
proteins, and glycosylation is known to affect, for instance, the protein stability (65). 
 
The physiological implications of the present thesis results are that the vitamin A 
status of a cancer patient receiving chemotherapy or γ-irradiation might influence the 
effect of the treatment. Thus, if the effects of RA on T cells mimic the effects on 
tumor cells, i.e. T cell lymphomas or T cell leukaemia, then it should not be 
recommended to have high vitamin A levels in plasma during the treatment. In fact, 
perhaps retinoic acid receptor antagonists could be used to enhance the effect of DNA 
damaging agents on apoptosis of the cancer cells. On the other hand, apoptosis of 
cells of the immune system is a serious side effect of most cancer treatments, leading 
to enhanced susceptibility to infections. Thus, in terms of protecting the patient’s T 
cells during cancer treatment, a high level of vitamin A should be recommended. 
More research is therefore clearly needed before justified recommendations as to 
vitamin A status and cancer treatments like irradiation and chemotherapy can be 
given. 
6. Conclusion 
6. Conclusion 
In the present study, we have shown that although RA markedly induces proliferation 
of normal T cells and inhibits B cells, DNA damage-induced apoptosis is inhibited in 
both cell types. This effect was particularly studied in T cells, demonstrating that 
DNA damage induced by both γ-irradiation and the cytotoxic agent doxorubicin was 
inhibited. One of the most important effector proteins in the DNA damage checkpoint 
is p53, and we showed that RA inhibited the DNA damage-induced p53 expression in 
stimulated T cells. Our result may have implications for cancer treatment, both by 
influencing the killing of malignant lymphocytes, as well as to protecting the immune 
system from unwanted damage during γ-irradiation or chemotherapy. 
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